{"recordsFiltered":48720,"recordsTotal":48720,"next":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=-days_late&start=46200","previous":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=-days_late&start=45600","results":[{"registry_id":"NCT07045194","publication_url":"https://clinicaltrials.gov/study/NCT07045194","title":"A Prospective, Multi-center, Single-blind, Randomized (1:1), Non-inferiority Study Comparing Clinical Outcomes of the Virtue® Sirolimus AngioInfusion™ Balloon (SAB) to the AGENT™ Paclitaxel Drug-Coated Balloon (DCB) in the Treatment of Coronary Artery In-stent Restenosis (ISR).","has_exemption":false,"start_date":"2025-10-20","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Orchestra BioMed, Inc","sponsor_slug":"orchestra-biomed-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07194850","publication_url":"https://clinicaltrials.gov/study/NCT07194850","title":"A Multicenter, Randomized, Double-blinded, Parallel-Arm, Placebo-Controlled, Pharmacokinetic and Pharmacodynamic Study Followed by an Open-Label Arm to Evaluate Efgartigimod IV in Pediatric Participants From 12 Years to Less Than 18 Years of Age With Chronic ITP","has_exemption":false,"start_date":"2025-10-20","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"argenx","sponsor_slug":"argenx","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07223021","publication_url":"https://clinicaltrials.gov/study/NCT07223021","title":"Improving EveNt Free Survival by Optimizing FLUdarabine Exposure During LymphodepletioN for CAR T CEll Therapy: a Randomized, Multi-center Study of Children and Young Adults With B-cell Acute Lymphoblastic Leukemia (INFLUENCE)","has_exemption":false,"start_date":"2025-10-20","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06878560","publication_url":"https://clinicaltrials.gov/study/NCT06878560","title":"EXPAND: A Prospective Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With End-stage Renal Disease (ESRD)","has_exemption":false,"start_date":"2025-10-29","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"United Therapeutics","sponsor_slug":"united-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07191912","publication_url":"https://clinicaltrials.gov/study/NCT07191912","title":"A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Long-Term Clinical Benefit of Govorestat in Patients With Charcot-Marie-Tooth-Sorbitol Dehydrogenase Deficiency (CMT-SORD)","has_exemption":false,"start_date":"2025-10-31","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Applied Therapeutics, Inc.","sponsor_slug":"applied-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07225751","publication_url":"https://clinicaltrials.gov/study/NCT07225751","title":"A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions","has_exemption":false,"start_date":"2025-11-25","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Kuros Biosurgery AG","sponsor_slug":"kuros-biosurgery-ag","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07357415","publication_url":"https://clinicaltrials.gov/study/NCT07357415","title":"A Phase 3b Study to Investigate the Efficacy and Safety of Different Retatrutide Dose Escalation Schemes in Participants Without Type 2 Diabetes Who Have Obesity or Overweight: A Randomized, Controlled, Double-Blind Trial","has_exemption":false,"start_date":"2026-01-24","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07389590","publication_url":"https://clinicaltrials.gov/study/NCT07389590","title":"A Pilot Study of Ublituximab in People With MS Experiencing Wearing Off Phenomena While Receiving Treatment With Ocrelizumab","has_exemption":false,"start_date":"2026-02-10","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06510309","publication_url":"https://clinicaltrials.gov/study/NCT06510309","title":"A Phase II Study Using Rituximab Plus Venetoclax in the Front Line Treatment of Marginal Zone Lymphoma","has_exemption":false,"start_date":"2026-02-11","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Gottfried von Keudell, MD PhD","sponsor_slug":"gottfried-von-keudell-md-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07291297","publication_url":"https://clinicaltrials.gov/study/NCT07291297","title":"Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma","has_exemption":false,"start_date":"2026-03-04","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07062354","publication_url":"https://clinicaltrials.gov/study/NCT07062354","title":"A Phase II Study of Combined Amivantamab, Carboplatin and Paclitaxel in Unresectable Locally Recurrent or Metastatic Head and Neck Cancer","has_exemption":false,"start_date":"2026-03-25","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"SWOG Cancer Research Network","sponsor_slug":"swog-cancer-research-network","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07225270","publication_url":"https://clinicaltrials.gov/study/NCT07225270","title":"A Randomized, Open-Label, Phase 3 Study of Rinatabart Sesutecan (Rina-S) Plus Standard of Care Versus Standard of Care as Maintenance Treatment After 2L Platinum-Based Doublet Chemotherapy in Participants With Recurrent Platinum-Sensitive Ovarian Cancer (PSOC)","has_exemption":false,"start_date":"2026-04-03","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Genmab","sponsor_slug":"genmab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06891885","publication_url":"https://clinicaltrials.gov/study/NCT06891885","title":"A Prospective, Open-label, Single-arm, Dose-escalation Study of the Safety and Tolerability of a Single Subretinal Uniocular Injection of Allogeneic Induced Pluripotent Stem Cell (iPSC)-Derived Retinal Sheets (DSP-3077) in Adults With Retinitis Pigmentosa (RP)","has_exemption":false,"start_date":"2026-04-16","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Sumitomo Pharma America, Inc.","sponsor_slug":"sumitomo-pharma-america-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06205589","publication_url":"https://clinicaltrials.gov/study/NCT06205589","title":"A Phase 2a/2b Study Evaluating Safety, Immunogenicity, and Therapeutic Efficacy of ID93 + GLA-SE Vaccination in Participants With Rifampicin-Susceptible Pulmonary TB","has_exemption":false,"start_date":"2026-07-01","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections","sponsor_slug":"advancing-clinical-therapeutics-globally-for-hivaids-and-other-infections","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05882344","publication_url":"https://clinicaltrials.gov/study/NCT05882344","title":"Cholinergic Deep Brain Stimulation for Alzheimer's Disease","has_exemption":false,"start_date":"2026-07-31","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07290777","publication_url":"https://clinicaltrials.gov/study/NCT07290777","title":"A Phase 2, Randomized, Partially Blinded, Controlled, Dose-ranging Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of VEL-101 in Kidney Transplant Recipients.","has_exemption":false,"start_date":"2026-07-31","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Veloxis Pharmaceuticals","sponsor_slug":"veloxis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07135687","publication_url":"https://clinicaltrials.gov/study/NCT07135687","title":"Oral Losartan to Decrease the Risk of Postoperative Arthrofibrosis Following Primary and Revision Anterior Cruciate Ligament Reconstruction","has_exemption":false,"start_date":"2026-08-31","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"Rush University Medical Center","sponsor_slug":"rush-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07566364","publication_url":"https://clinicaltrials.gov/study/NCT07566364","title":"A Phase 2 Study Of Mosunetuzumab In Patients With Chronic Lymphocytic Leukemia With Positive Measurable Residual Disease","has_exemption":false,"start_date":"2026-10-01","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06272201","publication_url":"https://clinicaltrials.gov/study/NCT06272201","title":"Incisionless Suture Plications in a POSE2.0 Interventional Randomized Obesity Study (The INSPIRO Study)","has_exemption":false,"start_date":"2026-10-31","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"USGI Medical","sponsor_slug":"usgi-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06916325","publication_url":"https://clinicaltrials.gov/study/NCT06916325","title":"DeLIVER Trial: A Prospective, Multi-Center, Single-Arm, Open Label Trial of Deceased Donor Livers Transplanted After DHOPE With eXVIVO LIVER Perfusion","has_exemption":false,"start_date":"2027-01-31","completion_date":"2028-10-31","has_results":false,"results_due":false,"sponsor_name":"XVIVO Perfusion","sponsor_slug":"xvivo-perfusion","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05517655","publication_url":"https://clinicaltrials.gov/study/NCT05517655","title":"BEGIN Novel ImagiNG Biomarkers","has_exemption":false,"start_date":"2022-05-01","completion_date":"2028-11-01","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06080503","publication_url":"https://clinicaltrials.gov/study/NCT06080503","title":"G-FORCE: Phase II Randomized Study of Glottic Larynx Hypofractionated Radiotherapy Versus ConvEntional Radiotherapy","has_exemption":false,"start_date":"2024-03-14","completion_date":"2028-11-01","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06709495","publication_url":"https://clinicaltrials.gov/study/NCT06709495","title":"Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas","has_exemption":false,"start_date":"2025-01-27","completion_date":"2028-11-01","has_results":false,"results_due":false,"sponsor_name":"David S Shulman, MD","sponsor_slug":"david-s-shulman-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06819007","publication_url":"https://clinicaltrials.gov/study/NCT06819007","title":"A Phase 3, Open-label, Multicenter, Randomized Trial of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy as First-line Maintenance Therapy in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01/ENGOT-ov89/GEICO144- O/GOG-3112/APGOT-OV13)","has_exemption":false,"start_date":"2025-03-19","completion_date":"2028-11-01","has_results":false,"results_due":false,"sponsor_name":"Daiichi Sankyo","sponsor_slug":"daiichi-sankyo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06973629","publication_url":"https://clinicaltrials.gov/study/NCT06973629","title":"A Two-Part Phase 3b Randomized, Double-Blind, Placebo-Controlled, Followed by Open-Label Extension, Multicenter Study of the Efficacy and Safety of MSC-NTF (NurOwn) in Participants With With Early Symptomatic and Moderate Disease Presentation in Amyotrophic Lateral Sclerosis (ALS)","has_exemption":false,"start_date":"2025-06-30","completion_date":"2028-11-01","has_results":false,"results_due":false,"sponsor_name":"Brainstorm-Cell Therapeutics","sponsor_slug":"brainstorm-cell-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07217301","publication_url":"https://clinicaltrials.gov/study/NCT07217301","title":"A Randomized, Open-Label, Multi-center, Phase 3 Study Evaluating the Efficacy and Safety of IBI363 Versus Docetaxel in Participants With Unresectable Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer With Disease Progression on or After Platinum-Based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy","has_exemption":false,"start_date":"2025-11-26","completion_date":"2028-11-01","has_results":false,"results_due":false,"sponsor_name":"Fortvita Biologics (USA)Inc.","sponsor_slug":"fortvita-biologics-usainc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07283731","publication_url":"https://clinicaltrials.gov/study/NCT07283731","title":"Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue Sarcoma","has_exemption":false,"start_date":"2026-06-02","completion_date":"2028-11-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07126561","publication_url":"https://clinicaltrials.gov/study/NCT07126561","title":"Phase II Open Label Trial of Trastuzumab Deruxtecan (Enhertu, DS-8210) in HER2 Positive Newly Diagnosed Metastatic Esophageal, Gastric, GEJ Cancer Patients With an ECOG Performance Status of 2","has_exemption":false,"start_date":"2026-11-01","completion_date":"2028-11-01","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07538336","publication_url":"https://clinicaltrials.gov/study/NCT07538336","title":"Targeting Interferon Gamma With Emapalumab to Lung Transplant Recipients With Interferon Gamma-high Acute Lung Allograft Dysfunction","has_exemption":false,"start_date":"2026-11-02","completion_date":"2028-11-01","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05931484","publication_url":"https://clinicaltrials.gov/study/NCT05931484","title":"A Phase 2, Double-Blind, Multi-Center, Placebo-Controlled Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetics of FHL-301 in Adult Patients With Parkinson's Disease","has_exemption":false,"start_date":"2027-11-01","completion_date":"2028-11-01","has_results":false,"results_due":false,"sponsor_name":"Forest Hills Lab","sponsor_slug":"forest-hills-lab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06152237","publication_url":"https://clinicaltrials.gov/study/NCT06152237","title":"A Multicenter, Open Label, Randomized, Dose-Escalation and Dose-Expansion Study of the Safety, Tolerability, and Efficacy of a Single Intrathecal Administration of TSHA-102, an AAV9-Delivered Gene Therapy, for the Treatment of Pediatric Females With Rett Syndrome","has_exemption":false,"start_date":"2023-12-12","completion_date":"2028-11-02","has_results":false,"results_due":false,"sponsor_name":"Taysha Gene Therapies, Inc.","sponsor_slug":"taysha-gene-therapies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07011745","publication_url":"https://clinicaltrials.gov/study/NCT07011745","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease","has_exemption":false,"start_date":"2025-07-16","completion_date":"2028-11-03","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06189313","publication_url":"https://clinicaltrials.gov/study/NCT06189313","title":"A Prospective, Multicenter Study to Evaluate the Safety and Efficacy of an Aspiration Thrombectomy System in Acute Pulmonary Embolism","has_exemption":false,"start_date":"2025-01-03","completion_date":"2028-11-04","has_results":false,"results_due":false,"sponsor_name":"Argon Medical Devices","sponsor_slug":"argon-medical-devices","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07160244","publication_url":"https://clinicaltrials.gov/study/NCT07160244","title":"A Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Multivalent Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Infants","has_exemption":false,"start_date":"2025-08-25","completion_date":"2028-11-06","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06504394","publication_url":"https://clinicaltrials.gov/study/NCT06504394","title":"A Phase 2 Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Pembrolizumab Coformulated With Hyaluronidase (MK-3475A) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL)","has_exemption":false,"start_date":"2024-10-14","completion_date":"2028-11-08","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04375800","publication_url":"https://clinicaltrials.gov/study/NCT04375800","title":"A Phase 2 Clinical Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Doravirine and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate in Participants With HIV-1, Who Are 4 Weeks to Less Than 12 Years of Age and Weigh Less Than 45 kg","has_exemption":false,"start_date":"2021-02-03","completion_date":"2028-11-12","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06161519","publication_url":"https://clinicaltrials.gov/study/NCT06161519","title":"Phase I/II Trial of PLX038 in Primary Central Nervous System Tumors With and Without MYC or MYCN Amplifications","has_exemption":false,"start_date":"2024-01-31","completion_date":"2028-11-14","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07301034","publication_url":"https://clinicaltrials.gov/study/NCT07301034","title":"Effects of Ziltivekimab Versus Placebo on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction. A Serial, Multivessel, Intravascular Ultrasound, Near-infrared Spectroscopy and Optical Coherence Tomography Imaging Study","has_exemption":false,"start_date":"2025-12-18","completion_date":"2028-11-14","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07335562","publication_url":"https://clinicaltrials.gov/study/NCT07335562","title":"A Phase 3, Randomized, Open-label, Multicenter Study to Compare the Efficacy and Safety of BMS-986353, CD19-targeted NEX-T CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis (Breakfree-SSc)","has_exemption":false,"start_date":"2026-04-30","completion_date":"2028-11-14","has_results":false,"results_due":false,"sponsor_name":"Juno Therapeutics, Inc., a Bristol-Myers Squibb Company","sponsor_slug":"juno-therapeutics-inc-a-bristol-myers-squibb-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04626024","publication_url":"https://clinicaltrials.gov/study/NCT04626024","title":"Safety And Efficacy Of Tyrosine Kinase Inhibitor Cessation For Chronic Myeloid Leukemia Patients With Stable Molecular Response In A Real World Population","has_exemption":false,"start_date":"2020-12-22","completion_date":"2028-11-15","has_results":false,"results_due":false,"sponsor_name":"Baylor College of Medicine","sponsor_slug":"baylor-college-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05051033","publication_url":"https://clinicaltrials.gov/study/NCT05051033","title":"Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY)","has_exemption":false,"start_date":"2022-02-21","completion_date":"2028-11-15","has_results":false,"results_due":false,"sponsor_name":"Annetine Gelijns","sponsor_slug":"annetine-gelijns","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06144606","publication_url":"https://clinicaltrials.gov/study/NCT06144606","title":"Phase 2 Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)","has_exemption":false,"start_date":"2023-12-26","completion_date":"2028-11-15","has_results":false,"results_due":false,"sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","sponsor_slug":"h-lee-moffitt-cancer-center-and-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06571383","publication_url":"https://clinicaltrials.gov/study/NCT06571383","title":"Weight Maintenance in Adolescents With Obesity; Long-Term Treatment With Semaglutide s.c.2.4 mg Once-weekly","has_exemption":false,"start_date":"2024-09-17","completion_date":"2028-11-15","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07092527","publication_url":"https://clinicaltrials.gov/study/NCT07092527","title":"Androgen Effects on the Reproductive Neuroendocrine Axis, 2025 Version","has_exemption":false,"start_date":"2025-12-05","completion_date":"2028-11-15","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07214779","publication_url":"https://clinicaltrials.gov/study/NCT07214779","title":"A Phase 3, Randomized, Open-Label Study of INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression","has_exemption":false,"start_date":"2025-12-09","completion_date":"2028-11-15","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05490277","publication_url":"https://clinicaltrials.gov/study/NCT05490277","title":"Vibrotactile Coordinated Reset for the Treatment of Chronic Stroke","has_exemption":false,"start_date":"2026-01-15","completion_date":"2028-11-15","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07411599","publication_url":"https://clinicaltrials.gov/study/NCT07411599","title":"Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial (\"Chip-CRC Trial\")","has_exemption":false,"start_date":"2026-04-20","completion_date":"2028-11-15","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07499232","publication_url":"https://clinicaltrials.gov/study/NCT07499232","title":"A Phase 3b, Multicenter, Randomized, Open-Label, Active-Controlled Study to Compare the Efficacy and Safety of Guselkumab Versus Risankizumab in the Treatment of Participants With Moderately to Severely Active Crohn's Disease","has_exemption":false,"start_date":"2026-04-20","completion_date":"2028-11-15","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07218809","publication_url":"https://clinicaltrials.gov/study/NCT07218809","title":"A Randomised, Open-label, Phase III Study of AZD5335 Versus Mirvetuximab Soravtansine in FRα-high and AZD5335 Versus Investigator's Choice Chemotherapy in FRα-low Expressing High-grade Platinum-resistant Epithelial Ovarian Cancer Patients (TREVI-OC-01)","has_exemption":false,"start_date":"2025-12-29","completion_date":"2028-11-17","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06499870","publication_url":"https://clinicaltrials.gov/study/NCT06499870","title":"Optimizing Treatment and Advanced Multi-Imaging Response Evaluation for Very-High-Risk Prostate Cancer (OPTIMAL) - a Phase II Single Arm Study","has_exemption":false,"start_date":"2024-09-06","completion_date":"2028-11-19","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06858735","publication_url":"https://clinicaltrials.gov/study/NCT06858735","title":"HYPERION CCA: a Phase 2 Trial of Systemic Therapy With or Without Liver-directed Radiation Therapy for Patients With Advanced Intrahepatic Cholangiocarcinoma","has_exemption":false,"start_date":"2025-06-10","completion_date":"2028-11-19","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07252050","publication_url":"https://clinicaltrials.gov/study/NCT07252050","title":"Ruxolitinib-Enhanced Conditioning for Pediatric and Young Adult Patients With Symptomatic Sickle Cell Disease Undergoing Haploidentical Hematopoietic Cell Transplantation","has_exemption":false,"start_date":"2026-04-10","completion_date":"2028-11-19","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06112379","publication_url":"https://clinicaltrials.gov/study/NCT06112379","title":"A Phase III, Open-label, Randomised Study of Neoadjuvant Datopotamab Deruxtecan (Dato-DXd) Plus Durvalumab Followed by Adjuvant Durvalumab With or Without Chemotherapy Versus Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Pembrolizumab With or Without Chemotherapy for the Treatment of Adult Patients With Previously Untreated Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer (D926QC00001; TROPION-Breast04)","has_exemption":false,"start_date":"2023-11-14","completion_date":"2028-11-20","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07430592","publication_url":"https://clinicaltrials.gov/study/NCT07430592","title":"A Phase 2B Trial of the Combination of SJ733 and Tafenoquine for Radical Cure of P. Vivax Malaria in Comparison to Chloroquine-Tafenoquine","has_exemption":false,"start_date":"2026-03-20","completion_date":"2028-11-20","has_results":false,"results_due":false,"sponsor_name":"R. Kiplin Guy","sponsor_slug":"r-kiplin-guy","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07011732","publication_url":"https://clinicaltrials.gov/study/NCT07011732","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease","has_exemption":false,"start_date":"2025-07-10","completion_date":"2028-11-24","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07257055","publication_url":"https://clinicaltrials.gov/study/NCT07257055","title":"Phase 2 Study of BTKi-Rituximab Induction Followed by Glofitamab Consolidation in High Risk Untreated MCL Patients - WINDOW-4 Study","has_exemption":false,"start_date":"2026-04-01","completion_date":"2028-11-24","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03686657","publication_url":"https://clinicaltrials.gov/study/NCT03686657","title":"A 26-week Single Site, Randomized, Double-blind, Active-controlled, Parallel Group, Human PoC Study to Evaluate Superiority of RK-01, Valsartan Plus Celecoxib Addon to Metformin Versus Metformin Alone in Type 2 Diabetes Patients","has_exemption":false,"start_date":"2025-10-10","completion_date":"2028-11-26","has_results":false,"results_due":false,"sponsor_name":"ARKAY Therapeutics","sponsor_slug":"arkay-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06947993","publication_url":"https://clinicaltrials.gov/study/NCT06947993","title":"A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase II Platform Study to Assess the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis","has_exemption":false,"start_date":"2025-05-16","completion_date":"2028-11-27","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06184152","publication_url":"https://clinicaltrials.gov/study/NCT06184152","title":"Contrast Ultrasound vs. Abbreviated MRI for Detection of HCC in Patients With Indeterminate Liver Nodules","has_exemption":false,"start_date":"2023-11-28","completion_date":"2028-11-28","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07321574","publication_url":"https://clinicaltrials.gov/study/NCT07321574","title":"An Open-Label, Multi-Cohort Phase IIb Clinical Study Evaluating the Efficacy and Safety of ABP1011T Tablets in Patients With Advanced Solid Tumors","has_exemption":false,"start_date":"2025-12-30","completion_date":"2028-11-28","has_results":false,"results_due":false,"sponsor_name":"Shanghai AB PharmaTech Ltd.","sponsor_slug":"shanghai-ab-pharmatech-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07221669","publication_url":"https://clinicaltrials.gov/study/NCT07221669","title":"An Open-Label Study to Assess the Efficacy and Safety of Multiple Doses of Salanersen (BIIB115) Delivered Intrathecally to Treatment-Naïve, Presymptomatic Infants With Genetically Diagnosed Spinal Muscular Atrophy","has_exemption":false,"start_date":"2026-04-28","completion_date":"2028-11-28","has_results":false,"results_due":false,"sponsor_name":"Biogen","sponsor_slug":"biogen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06649110","publication_url":"https://clinicaltrials.gov/study/NCT06649110","title":"A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of LTP001 in Healthy Adult Participants (Part A) and to Evaluate the Efficacy and Safety of LTP001 for the Treatment of Participants With Pulmonary Arterial Hypertension (Part B)","has_exemption":false,"start_date":"2024-10-24","completion_date":"2028-11-29","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06593522","publication_url":"https://clinicaltrials.gov/study/NCT06593522","title":"A Phase 2 Study Evaluating the Efficacy, Safety, Tolerability, and Pharmacokinetics of Anvumetostat in Subjects With Methylthioadenosine Phosphorylase (MTAP)-Deleted Previously Treated Advanced Non-Small Cell Lung Cancer (NSCLC)","has_exemption":false,"start_date":"2024-12-26","completion_date":"2028-11-29","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT00682318","publication_url":"https://clinicaltrials.gov/study/NCT00682318","title":"Effects of Fish Oil and Red Wine on Oxidative Stress Biomarkers: a Randomized Double-blinded Trial on the Modulation of the Eicosanoid and Isoprostane Pathways in Healthy Subjects by Omega-3 Polyunsaturated Fatty Acids and Red Wine.","has_exemption":false,"start_date":"2008-05-31","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Carsten Skarke, MD","sponsor_slug":"carsten-skarke-md","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03301506","publication_url":"https://clinicaltrials.gov/study/NCT03301506","title":"ASSURE: An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)","has_exemption":false,"start_date":"2017-12-12","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03833921","publication_url":"https://clinicaltrials.gov/study/NCT03833921","title":"Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity, PSA Decline and Genetic Variation in Proteins Involved in Androgen Metabolism in Metastatic Hormone Naive Prostate Cancer","has_exemption":false,"start_date":"2019-05-23","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Martha Mims","sponsor_slug":"martha-mims","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04781972","publication_url":"https://clinicaltrials.gov/study/NCT04781972","title":"Multimodal Brain Imaging of the Neural Effects of Methylphenidate in Patients With ADHD","has_exemption":false,"start_date":"2021-07-27","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05079841","publication_url":"https://clinicaltrials.gov/study/NCT05079841","title":"The Stimulation To Induce Mothers (STIM) Study: A Parallel Group Randomized Controlled Trial","has_exemption":false,"start_date":"2021-11-15","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05228145","publication_url":"https://clinicaltrials.gov/study/NCT05228145","title":"A Phase 1/2 Intracerebroventricular and Intravitreal Administration of NGN-101 for Treatment of Neuronal Ceroid Lipofuscinosis (NCL) Subtype 5 (CLN5) Disease","has_exemption":false,"start_date":"2022-01-31","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Neurogene Inc.","sponsor_slug":"neurogene-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05076617","publication_url":"https://clinicaltrials.gov/study/NCT05076617","title":"An Open-Label, Multicenter, Outpatient Extension Study to Evaluate the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures","has_exemption":false,"start_date":"2022-02-03","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"UCB Biopharma SRL","sponsor_slug":"ucb-biopharma-srl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05121376","publication_url":"https://clinicaltrials.gov/study/NCT05121376","title":"A Phase 1/2 Open-Label, Dose-Escalation Study to Determine the Safety Tolerability & Efficacy of BMN 331 an AAV Vector-Mediated Gene Transfer of Human SERPING1 Gene in Subjects With HAE Due to Human C1-INH Deficiency","has_exemption":false,"start_date":"2022-02-15","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"BioMarin Pharmaceutical","sponsor_slug":"biomarin-pharmaceutical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05281731","publication_url":"https://clinicaltrials.gov/study/NCT05281731","title":"Sonobiopsy for Noninvasive and Sensitive Detection of Glioblastoma","has_exemption":false,"start_date":"2022-04-18","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05278208","publication_url":"https://clinicaltrials.gov/study/NCT05278208","title":"Phase I/II Study of Lutathera in Patients With Recurrent and/or Progressive High-Grade Central Nervous System Tumors and Meningiomas That Demonstrate Uptake on DOTATATE PET","has_exemption":false,"start_date":"2022-11-21","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Nationwide Children's Hospital","sponsor_slug":"nationwide-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05796375","publication_url":"https://clinicaltrials.gov/study/NCT05796375","title":"Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance","has_exemption":false,"start_date":"2023-11-17","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"White River Junction Veterans Affairs Medical Center","sponsor_slug":"white-river-junction-veterans-affairs-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06157528","publication_url":"https://clinicaltrials.gov/study/NCT06157528","title":"Diagnosis of Pelvic Endometriosis: a Preliminary Study on the Added Value of R2*MFGRE Sequence in MRI","has_exemption":false,"start_date":"2023-12-20","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Zhenshen Ma","sponsor_slug":"zhenshen-ma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06169852","publication_url":"https://clinicaltrials.gov/study/NCT06169852","title":"Stimulus-Evoked Directional Field Potentials to Guide Subthalamic and Pallidal DBS for PD","has_exemption":false,"start_date":"2024-01-12","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06075953","publication_url":"https://clinicaltrials.gov/study/NCT06075953","title":"DCIS: RECAST Trial -Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment: a Breast Cancer Prevention Pilot Study","has_exemption":false,"start_date":"2024-02-17","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"QuantumLeap Healthcare Collaborative","sponsor_slug":"quantumleap-healthcare-collaborative","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05940324","publication_url":"https://clinicaltrials.gov/study/NCT05940324","title":"Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)","has_exemption":false,"start_date":"2024-02-24","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06316297","publication_url":"https://clinicaltrials.gov/study/NCT06316297","title":"A Phase I/II, Randomized, Placebo-controlled, Multi-arm, Dose-finding Study to Evaluate the Safety, Efficacy and Immunogenicity of an Acne mRNA Vaccine Candidate in Adults With Moderate to Severe Acne 18 to 45 Years of Age","has_exemption":false,"start_date":"2024-04-05","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Sanofi Pasteur, a Sanofi Company","sponsor_slug":"sanofi-pasteur-a-sanofi-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06295159","publication_url":"https://clinicaltrials.gov/study/NCT06295159","title":"Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma","has_exemption":false,"start_date":"2024-05-17","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","sponsor_slug":"h-lee-moffitt-cancer-center-and-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06284122","publication_url":"https://clinicaltrials.gov/study/NCT06284122","title":"A Phase III Randomized, Open-label, International, Multicenter Study Evaluating the Efficacy and Safety of Mosunetuzumab Plus Lenalidomide in Comparison to Anti-CD20 Monoclonal Antibody Plus Chemotherapy in Subjects With Previously Untreated FLIPI 2-5 Follicular Lymphoma","has_exemption":false,"start_date":"2024-06-07","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"The Lymphoma Academic Research Organisation","sponsor_slug":"the-lymphoma-academic-research-organisation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05869682","publication_url":"https://clinicaltrials.gov/study/NCT05869682","title":"Phase 2 Study of Bright White Light During Treatment With ADT Combination Therapy in Men With Advanced Prostate Cancer to PreServe PHysIcal and MeNtal HEalth (SHINE)","has_exemption":false,"start_date":"2024-07-09","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06535607","publication_url":"https://clinicaltrials.gov/study/NCT06535607","title":"A Phase II, Multi-Center Study to Evaluate the Efficacy and Safety of Volrustomig as Monotherapy or in Combination With Anti-cancer Agents in Participants With Advanced/Metastatic Solid Tumors","has_exemption":false,"start_date":"2024-08-22","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06467305","publication_url":"https://clinicaltrials.gov/study/NCT06467305","title":"Sensorimotor Basis of Speech Motor Learning and Retention","has_exemption":false,"start_date":"2024-10-01","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06491823","publication_url":"https://clinicaltrials.gov/study/NCT06491823","title":"Sensorimotor Basis of Speech Motor Learning and Retention","has_exemption":false,"start_date":"2024-10-01","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06467292","publication_url":"https://clinicaltrials.gov/study/NCT06467292","title":"Sensorimotor Basis of Speech Motor Learning and Retention","has_exemption":false,"start_date":"2024-10-01","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06487221","publication_url":"https://clinicaltrials.gov/study/NCT06487221","title":"A Phase II Trial of Avutometinib in Combination With Defactinib in Metastatic Diffuse Gastric Cancer","has_exemption":false,"start_date":"2024-10-28","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Ryan H. Moy, MD, PhD","sponsor_slug":"ryan-h-moy-md-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06655896","publication_url":"https://clinicaltrials.gov/study/NCT06655896","title":"A Phase II, Multi-part, Randomized, Open-label, Assessor-blinded, Active-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Rapcabtagene Autoleucel Versus Rituximab Treatment in Participants With Severe Refractory Diffuse Cutaneous Systemic Sclerosis","has_exemption":false,"start_date":"2024-10-29","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06111313","publication_url":"https://clinicaltrials.gov/study/NCT06111313","title":"A Phase 2 Risk Adapted Parallel Randomized Trial of MRI-Guided Lattice Stereotactic Focal Radiotherapy of the Prostate With or Without Ultra-Short Term Androgen Deprivation Therapy-The Miami UAdapt Trial","has_exemption":false,"start_date":"2024-11-06","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06703476","publication_url":"https://clinicaltrials.gov/study/NCT06703476","title":"A Clinically Integrated Randomized Clinical Trial (RCT) of Modifications to Radical Cystectomy and Postoperative Care","has_exemption":false,"start_date":"2024-11-21","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06463457","publication_url":"https://clinicaltrials.gov/study/NCT06463457","title":"Comeback From Long coursE ADT With RElugolix and Darolutamide in Hormone-sensitive Prostate Cancer (CLEARED)","has_exemption":false,"start_date":"2024-12-13","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Atish Choudhury, MD","sponsor_slug":"atish-choudhury-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06846541","publication_url":"https://clinicaltrials.gov/study/NCT06846541","title":"An Extension Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Long-term Safety, Efficacy, and Durability of Response to ESK-001","has_exemption":false,"start_date":"2025-01-08","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Alumis Inc","sponsor_slug":"alumis-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06822738","publication_url":"https://clinicaltrials.gov/study/NCT06822738","title":"A Prospective, Multicenter Clinical Study to Evaluate the Safety and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Subjects With Glaucoma","has_exemption":false,"start_date":"2025-02-11","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06679634","publication_url":"https://clinicaltrials.gov/study/NCT06679634","title":"Retinoblastoma Phase II Expanded Access Clinical Trial","has_exemption":false,"start_date":"2025-02-21","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Targeted Therapy Technologies, LLC","sponsor_slug":"targeted-therapy-technologies-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06829238","publication_url":"https://clinicaltrials.gov/study/NCT06829238","title":"Assessment of Metformin for Restoration of Immune Homeostasis in HIV+ and HIV- Individuals With a History of Injection Drug Use (MET-IH)","has_exemption":false,"start_date":"2025-04-07","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07301177","publication_url":"https://clinicaltrials.gov/study/NCT07301177","title":"AtMS for Alleviating Posttraumatic Peripheral Neuropathic Pain (PTP-NP)","has_exemption":false,"start_date":"2025-04-30","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Veterans Medical Research Foundation","sponsor_slug":"veterans-medical-research-foundation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06271590","publication_url":"https://clinicaltrials.gov/study/NCT06271590","title":"The MAGICAL SV Trial - A Prospective, Multicenter, Randomized, Two-Arm, Single-blind Non Inferiority Trial to Evaluate the Safety and Efficacy of the MagicTouch™ Sirolimus-Coated Balloon in the Treatment of Small Vessels in Patients With Coronary Artery Disease.","has_exemption":false,"start_date":"2025-05-20","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Concept Medical Inc.","sponsor_slug":"concept-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07013110","publication_url":"https://clinicaltrials.gov/study/NCT07013110","title":"An Artificial Intelligence-powered Approach to Precision Immunotherapy of Human Arthritis - A Double-blind, Randomized, Placebo-controlled Clinical Trial","has_exemption":false,"start_date":"2025-06-18","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Prof Salvatore Albani","sponsor_slug":"prof-salvatore-albani","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07064759","publication_url":"https://clinicaltrials.gov/study/NCT07064759","title":"A Phase 3, Randomized, Double-Masked, Active-Controlled Trial of a Single Intravitreal Injection of 4D-150 in Adults With Macular Neovascularization Secondary to Age-Related Macular Degeneration","has_exemption":false,"start_date":"2025-07-22","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"4D Molecular Therapeutics","sponsor_slug":"4d-molecular-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07124910","publication_url":"https://clinicaltrials.gov/study/NCT07124910","title":"Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure Versus a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases","has_exemption":false,"start_date":"2025-08-01","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Woolfson Eye Institute","sponsor_slug":"woolfson-eye-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07135167","publication_url":"https://clinicaltrials.gov/study/NCT07135167","title":"Compassionate Use Study of Epi-ON Corneal Collagen Crosslinking Performed Using UVA Exposure on Eyes With Ectatic Corneal Diseases for Subjects With Down Syndrome","has_exemption":false,"start_date":"2025-08-01","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Woolfson Eye Institute","sponsor_slug":"woolfson-eye-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07188844","publication_url":"https://clinicaltrials.gov/study/NCT07188844","title":"An Open-Label Extension Study to Assess Long-term Safety and Tolerability of Batoclimab in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)","has_exemption":false,"start_date":"2025-08-28","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Immunovant Sciences GmbH","sponsor_slug":"immunovant-sciences-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07047144","publication_url":"https://clinicaltrials.gov/study/NCT07047144","title":"A Phase 2, Double-Blind Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Apitegromab in Subjects <2 Years Old With Spinal Muscular Atrophy (SMA)","has_exemption":false,"start_date":"2025-09-15","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Scholar Rock, Inc.","sponsor_slug":"scholar-rock-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07222085","publication_url":"https://clinicaltrials.gov/study/NCT07222085","title":"Determining the Long-Term Stability of the Glide Control Strategy for Upper Limb Prostheses","has_exemption":false,"start_date":"2025-10-15","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Infinite Biomedical Technologies","sponsor_slug":"infinite-biomedical-technologies","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06793215","publication_url":"https://clinicaltrials.gov/study/NCT06793215","title":"A Phase III, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Patients With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2025-10-24","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06989775","publication_url":"https://clinicaltrials.gov/study/NCT06989775","title":"EnCompass Clamp and the AtriClip in Box Lesion and Left Atrial Appendage EXclusion Procedure for the Prevention of New Onset of Atrial Fibrillation","has_exemption":false,"start_date":"2025-10-24","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"AtriCure, Inc.","sponsor_slug":"atricure-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06659445","publication_url":"https://clinicaltrials.gov/study/NCT06659445","title":"A Phase 2 Multicenter, Randomized, Double-masked, Sham-controlled, Reference-arm Study to Evaluate Efficacy and Safety of ONL1204 in Patients With Geographic Atrophy (GA) Associated With Age-related Macular Degeneration (AMD)","has_exemption":false,"start_date":"2025-10-28","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"ONL Therapeutics","sponsor_slug":"onl-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07216742","publication_url":"https://clinicaltrials.gov/study/NCT07216742","title":"A Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Efficacy and Safety of a Human Menopausal Gonadotropin in the Development of Multiple Follicles, Pregnancy, and Cumulative Live Birth as Part of an Assisted Reproductive Technology (ART) Cycle.","has_exemption":false,"start_date":"2025-11-01","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Granata Bio Corporation","sponsor_slug":"granata-bio-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07032792","publication_url":"https://clinicaltrials.gov/study/NCT07032792","title":"Factor VIII Inhibitor Bypass Activity (FEIBA) Versus Fresh Frozen Plasma As First Line Therapy For Bleeding After Cardiac Surgery","has_exemption":false,"start_date":"2025-11-03","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06455319","publication_url":"https://clinicaltrials.gov/study/NCT06455319","title":"Precision Administration of Anti-thymocyte Globulin With or Without Verapamil in Adolescents and Young Adults With Type 1 Diabetes","has_exemption":false,"start_date":"2025-11-12","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07387978","publication_url":"https://clinicaltrials.gov/study/NCT07387978","title":"A Pilot Study to Describe the Effect of Photobiomodulation in Reducing the Severity and Incidence of Oral Mucositis in Oral Cancer Patients Undergoing Radiation Treatment","has_exemption":false,"start_date":"2025-11-26","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Peter MacCallum Cancer Centre, Australia","sponsor_slug":"peter-maccallum-cancer-centre-australia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07117669","publication_url":"https://clinicaltrials.gov/study/NCT07117669","title":"A Phase 1/2, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation and Expansion Study of ENP-501 in Non-Peanut Allergic Participants and Participants With a Known Peanut Allergy","has_exemption":false,"start_date":"2025-12-16","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"N-Fold, LLC","sponsor_slug":"n-fold-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07228247","publication_url":"https://clinicaltrials.gov/study/NCT07228247","title":"A Phase Ⅰ/Ⅱa Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of HMPL-A251 in Participants With Advanced or Metastatic HER2-Expressing Solid Tumors","has_exemption":false,"start_date":"2025-12-16","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Hutchmed","sponsor_slug":"hutchmed","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06575075","publication_url":"https://clinicaltrials.gov/study/NCT06575075","title":"A Double-blind, Placebo-controlled Study to Determine the Safety and Feasibility of Two Doses of Intravenous (2R, 6R)-Hydroxynorketamine (RR-HNK) in Adults With Obsessive-Compulsive Disorder","has_exemption":false,"start_date":"2026-01-23","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Carolyn Rodriguez","sponsor_slug":"carolyn-rodriguez","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07091279","publication_url":"https://clinicaltrials.gov/study/NCT07091279","title":"Randomized Controlled Trial of Propranolol for Aggression, Self-Injury, and Severe Disruptive Behavior in Adolescents and Adults With Autism","has_exemption":false,"start_date":"2026-01-30","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Jeremy Veenstra-vanderweele","sponsor_slug":"jeremy-veenstra-vanderweele","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07344220","publication_url":"https://clinicaltrials.gov/study/NCT07344220","title":"Metastatic Non-Familial Adenocarcinoma Maintenance Therapy With DZ-002: Heptamine Carboxymethine Dye Conjugate","has_exemption":false,"start_date":"2026-01-31","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Hoag Memorial Hospital Presbyterian","sponsor_slug":"hoag-memorial-hospital-presbyterian","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07449702","publication_url":"https://clinicaltrials.gov/study/NCT07449702","title":"An Open-label Extension Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of ORKA-001 in Participants With Moderate-to-Severe Plaque Psoriasis","has_exemption":false,"start_date":"2026-02-23","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Oruka Therapeutics, Inc.","sponsor_slug":"oruka-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07424378","publication_url":"https://clinicaltrials.gov/study/NCT07424378","title":"Randomized Controlled Trial of Epoprostenol Versus Placebo in Addition to Standard Therapy for Severe Frostbite Injury","has_exemption":false,"start_date":"2026-02-28","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06434064","publication_url":"https://clinicaltrials.gov/study/NCT06434064","title":"A Pilot, Single-Arm, Phase II Trial of Tamoxifen Plus Pegylated Liposomal Doxorubicin in Patients With Metastatic Triple Negative Breast Cancer","has_exemption":false,"start_date":"2026-03-03","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Roswell Park Cancer Institute","sponsor_slug":"roswell-park-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07227025","publication_url":"https://clinicaltrials.gov/study/NCT07227025","title":"A Phase 1/2 Study Evaluating the Safety and Efficacy of Amivantamab and Olomorasib Combination Therapy in Metastatic Non-small Cell Lung Cancer","has_exemption":false,"start_date":"2026-03-03","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07407933","publication_url":"https://clinicaltrials.gov/study/NCT07407933","title":"A Phase Ib/II, Multicenter, Open-Label Study to Evaluate Safety, Efficacy, and Pharmacokinetics of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors","has_exemption":false,"start_date":"2026-03-31","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"MediLink Therapeutics (Suzhou) Co., Ltd.","sponsor_slug":"medilink-therapeutics-suzhou-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07107334","publication_url":"https://clinicaltrials.gov/study/NCT07107334","title":"A Pilot Study to Estimate Early Clinical Efficacy Signals of a Glucagon-like Peptide 1 Receptor Agonist (GLP-1RA) Administration in Conjunction With Levonorgestrel Intrauterine Device (LNG-IUD) in Obese Patients With Endometrioid Intraepithelial Neoplasia","has_exemption":false,"start_date":"2026-04-07","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07326566","publication_url":"https://clinicaltrials.gov/study/NCT07326566","title":"A Phase 2 Randomized, Multicenter Study to Evaluate the Efficacy and Safety of Silevertinib, an Oral EGFR Inhibitor, in Combination With Temozolomide in Patients With Newly Diagnosed Glioblastoma With Unmethylated MGMT Promoter and EGFRvIII","has_exemption":false,"start_date":"2026-04-30","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Black Diamond Therapeutics, Inc.","sponsor_slug":"black-diamond-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07428746","publication_url":"https://clinicaltrials.gov/study/NCT07428746","title":"Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetes","has_exemption":false,"start_date":"2026-04-30","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07527299","publication_url":"https://clinicaltrials.gov/study/NCT07527299","title":"Assessment of the Safety and Effectiveness of the VARIPULSE™ Catheter System in the Treatment of Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein (With or Without Posterior Wall Isolation) and Superior Vena Cava Isolation: A Randomized Controlled Trial","has_exemption":false,"start_date":"2026-05-29","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Biosense Webster, Inc.","sponsor_slug":"biosense-webster-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07571135","publication_url":"https://clinicaltrials.gov/study/NCT07571135","title":"Letermovir Versus Valganciclovir for 90 Days in CMV Seropositive Kidney Transplant Recipients: Results of a Single-center Experience.","has_exemption":false,"start_date":"2026-05-31","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"Elisabeth Kincaide","sponsor_slug":"elisabeth-kincaide","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07393555","publication_url":"https://clinicaltrials.gov/study/NCT07393555","title":"A Randomized Phase II Study of Sacituzumab Govitecan Alone, Ivonescimab Alone, or Sacituzumab Govitecan and Ivonescimab in Participants With Previously-Treated Actionable Genomic Alteration Positive Stage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP Sub-Study)","has_exemption":false,"start_date":"2026-08-07","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"SWOG Cancer Research Network","sponsor_slug":"swog-cancer-research-network","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07570654","publication_url":"https://clinicaltrials.gov/study/NCT07570654","title":"A Phase 2b/3, Multicentre, Randomised, Double-blind, Controlled Trial, With an Open Label Extension, to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder","has_exemption":false,"start_date":"2026-09-30","completion_date":"2028-11-30","has_results":false,"results_due":false,"sponsor_name":"COMPASS Pathways","sponsor_slug":"compass-pathways","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03148106","publication_url":"https://clinicaltrials.gov/study/NCT03148106","title":"Optimizing Peripheral Stimulation Parameters to Modulate the Sensorimotor Cortex for Post-stroke Motor Recovery.","has_exemption":false,"start_date":"2017-04-04","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03217110","publication_url":"https://clinicaltrials.gov/study/NCT03217110","title":"Cerebellar Transcranial Magnetic Stimulation and Cognitive Control","has_exemption":false,"start_date":"2017-11-30","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"Krystal Parker, PhD","sponsor_slug":"krystal-parker-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04303117","publication_url":"https://clinicaltrials.gov/study/NCT04303117","title":"Phase I/II Study of PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma","has_exemption":false,"start_date":"2020-07-13","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04588077","publication_url":"https://clinicaltrials.gov/study/NCT04588077","title":"Comparison the Seroconversion Rate Between Two-dose and Three-dose Regimens of Heplisav B Among Patients With Cirrhosis, a Randomized-control Prospective Study.","has_exemption":false,"start_date":"2020-09-14","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"Mercy Medical Center","sponsor_slug":"mercy-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04825522","publication_url":"https://clinicaltrials.gov/study/NCT04825522","title":"The Effect of Intrawound Vancomycin Powder in Spine Surgery: A Prospective Randomized Controlled Trial","has_exemption":false,"start_date":"2022-03-27","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"Windsor-Essex Compassionate Care Community","sponsor_slug":"windsor-essex-compassionate-care-community","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05303519","publication_url":"https://clinicaltrials.gov/study/NCT05303519","title":"A Phase 3, Multicenter, Clinical Study to Evaluate the Efficacy and Safety of Safusidenib Erbumine in Participants With Isocitrate Dehydrogenase 1 (IDH1)-Mutant Glioma","has_exemption":false,"start_date":"2023-06-05","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"Nuvation Bio, Inc.","sponsor_slug":"nuvation-bio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06082947","publication_url":"https://clinicaltrials.gov/study/NCT06082947","title":"αβT Cell/CD19+ B Cell Depletion for Alternative Donor Allogeneic Hematopoietic Cell Transplantation (HSCT) for Children and Young Adults With Hematologic Malignancies","has_exemption":false,"start_date":"2023-12-18","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"Nationwide Children's Hospital","sponsor_slug":"nationwide-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06168942","publication_url":"https://clinicaltrials.gov/study/NCT06168942","title":"Laminar Left Atrial Appendage Elimination (LAAX) Pivotal IDE Study","has_exemption":false,"start_date":"2024-02-19","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"Biosense Webster, Inc.","sponsor_slug":"biosense-webster-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06312813","publication_url":"https://clinicaltrials.gov/study/NCT06312813","title":"Pilot Studies Evaluating Use of Topical Imipramine and Amitriptyline in Reducing Ultraviolet B Light-Induced Redness in Patients With Rosacea","has_exemption":false,"start_date":"2024-02-27","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"Wright State University","sponsor_slug":"wright-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06282575","publication_url":"https://clinicaltrials.gov/study/NCT06282575","title":"An Open-label Randomized Trial of the Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy Alone for Advanced HER2-positive Biliary Tract Cancer","has_exemption":false,"start_date":"2024-07-19","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"Jazz Pharmaceuticals","sponsor_slug":"jazz-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06493370","publication_url":"https://clinicaltrials.gov/study/NCT06493370","title":"Intravenous Ascorbate Plus Gemcitabine/Carboplatin: A Novel and Cost-Effective Alternative With Evident Efficacy in Patients With Muscle Invasive Bladder Cancer","has_exemption":false,"start_date":"2025-01-16","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"University of Kansas Medical Center","sponsor_slug":"university-of-kansas-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06216535","publication_url":"https://clinicaltrials.gov/study/NCT06216535","title":"Escitalopram in Asthma Patients With Frequent Exacerbation","has_exemption":false,"start_date":"2025-05-19","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07258446","publication_url":"https://clinicaltrials.gov/study/NCT07258446","title":"PRAME (Preferentially Expressed Antigen in Melanoma) Immunohistochemistry Guided Slow-Mohs Micrographic Surgery of Malignant Melanoma: A Pragmatic Clinical Trial","has_exemption":false,"start_date":"2025-10-24","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06419439","publication_url":"https://clinicaltrials.gov/study/NCT06419439","title":"Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid Depression","has_exemption":false,"start_date":"2025-12-03","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07226856","publication_url":"https://clinicaltrials.gov/study/NCT07226856","title":"Phase 2, Single-Arm Trial of BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-Paclitaxel in the First Line Setting of Advanced Pancreatic Adenocarcinoma","has_exemption":false,"start_date":"2025-12-12","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07280169","publication_url":"https://clinicaltrials.gov/study/NCT07280169","title":"Identifying Non-Union Rates Using Carbo-fix Lateral Plate Devices and Standard Plate-Nail Construct in Distal Femur Fractures","has_exemption":false,"start_date":"2026-01-29","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"University of Missouri-Columbia","sponsor_slug":"university-of-missouri-columbia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07237048","publication_url":"https://clinicaltrials.gov/study/NCT07237048","title":"Effect of Oral Minocycline in Patients With Acute Stroke - a Randomized, Open Label, Prospective Trial","has_exemption":false,"start_date":"2026-02-02","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"Joyce Chen","sponsor_slug":"joyce-chen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07199192","publication_url":"https://clinicaltrials.gov/study/NCT07199192","title":"A Multicenter, Randomized, Controlled Trial to Evaluate the Effectiveness and Safety of Systemic Corticosteroid Treatment for Hospitalized Patients With Severe Acute Respiratory Infection and Hypoxemia (STRIVE 003)","has_exemption":false,"start_date":"2026-03-01","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07017829","publication_url":"https://clinicaltrials.gov/study/NCT07017829","title":"A Phase II Trial of GT103 in Combination With Pembrolizumab in STK11 Mutant Non-Small Cell Lung Cancer (NSCLC)","has_exemption":false,"start_date":"2026-04-01","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"Roswell Park Cancer Institute","sponsor_slug":"roswell-park-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06965504","publication_url":"https://clinicaltrials.gov/study/NCT06965504","title":"Initiation and Titration of Guideline Directed Medical Therapy in Heart Failure Cardiogenic Shock With Impella 5.5 for Cardiac Recovery: INTeGRATE","has_exemption":false,"start_date":"2026-04-01","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"Abiomed Inc.","sponsor_slug":"abiomed-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07095894","publication_url":"https://clinicaltrials.gov/study/NCT07095894","title":"A Randomized Placebo-controlled Trial of Spectacles With Highly Aspherical Lenslet Target (H.A.L.T.) MAX Technology or 0.05% Atropine to Slow Progression of Myopia in Children","has_exemption":false,"start_date":"2026-05-01","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"Jaeb Center for Health Research","sponsor_slug":"jaeb-center-for-health-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07228195","publication_url":"https://clinicaltrials.gov/study/NCT07228195","title":"SGLT2i Therapy in Islet Transplantation (SIT)","has_exemption":false,"start_date":"2026-05-15","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07463521","publication_url":"https://clinicaltrials.gov/study/NCT07463521","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis","has_exemption":false,"start_date":"2026-05-29","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"UCB Biopharma SRL","sponsor_slug":"ucb-biopharma-srl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07535489","publication_url":"https://clinicaltrials.gov/study/NCT07535489","title":"A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of IPG11406 Tablets in Adult Patients With Moderately to Severely Active Ulcerative Colitis","has_exemption":false,"start_date":"2026-07-07","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"Nanjing Immunophage Biotech Co., Ltd","sponsor_slug":"nanjing-immunophage-biotech-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07349693","publication_url":"https://clinicaltrials.gov/study/NCT07349693","title":"A Randomized Trial to Assess the Efficacy and Safety of Cerebraca Wafer Plus Temozolomide Versus Temozolomide Alone in Recurrent Glioblastoma","has_exemption":false,"start_date":"2026-11-01","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"Everfront Biotech Co., Ltd.","sponsor_slug":"everfront-biotech-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03787290","publication_url":"https://clinicaltrials.gov/study/NCT03787290","title":"Examining Immune-Based Mechanisms of Action for Mild-Intensity Whole Body Hyperthermia (WBH) in the Treatment of Major Depressive Disorder","has_exemption":false,"start_date":"2026-12-01","completion_date":"2028-12-01","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06634589","publication_url":"https://clinicaltrials.gov/study/NCT06634589","title":"A Phase 1b/2, Open-Label, Master Protocol Study of BTK-Degrader BGB-16673 in Combination With Other Agents in Patients With Relapsed or Refractory B-Cell Malignancies","has_exemption":false,"start_date":"2024-11-27","completion_date":"2028-12-02","has_results":false,"results_due":false,"sponsor_name":"BeOne Medicines","sponsor_slug":"beone-medicines","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05205174","publication_url":"https://clinicaltrials.gov/study/NCT05205174","title":"Depth Electrode Detection of Cortical Spreading Depolarization After Traumatic Brain Injury","has_exemption":false,"start_date":"2025-04-03","completion_date":"2028-12-03","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07134088","publication_url":"https://clinicaltrials.gov/study/NCT07134088","title":"A Phase 1b/2 Study to Investigate the Safety, Efficacy and Pharmacokinetics of Administration of Subcutaneous (SC) Blinatumomab in Pediatric Participants With Relapsed/Refractory (R/R) and Minimal Residual Disease Positive (MRD+) B-Cell Precursor Acute Lymphoblastic Leukemia (B-ALL)","has_exemption":false,"start_date":"2025-12-08","completion_date":"2028-12-05","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07540988","publication_url":"https://clinicaltrials.gov/study/NCT07540988","title":"A Double-blind, Randomized, Placebo-controlled Trial Investigating the Efficacy and Safety of Nerandomilast Over at Least 52 Weeks in Patients With Fibrosing Interstitial Lung Disease at Risk for Disease Progression (FIBRONEER-ACT)","has_exemption":false,"start_date":"2026-08-28","completion_date":"2028-12-05","has_results":false,"results_due":false,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07438496","publication_url":"https://clinicaltrials.gov/study/NCT07438496","title":"A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus","has_exemption":false,"start_date":"2026-03-05","completion_date":"2028-12-06","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07569081","publication_url":"https://clinicaltrials.gov/study/NCT07569081","title":"A Randomized Phase 2/3, Double-blind, Placebo Controlled Adaptive Study Evaluating the Efficacy and Safety of Momelotinib in Participants With VEXAS Syndrome","has_exemption":false,"start_date":"2026-08-05","completion_date":"2028-12-06","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07218029","publication_url":"https://clinicaltrials.gov/study/NCT07218029","title":"An Open-label Long-term Follow-up Study to Evaluate the Effects of Sotatercept When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH (MK-7962-038)","has_exemption":false,"start_date":"2021-05-12","completion_date":"2028-12-07","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06596694","publication_url":"https://clinicaltrials.gov/study/NCT06596694","title":"A Phase 1/2 Study to Evaluate the Safety and Efficacy of Patritumab Deruxtecan in Gastrointestinal Cancers","has_exemption":false,"start_date":"2024-11-03","completion_date":"2028-12-07","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05083169","publication_url":"https://clinicaltrials.gov/study/NCT05083169","title":"A Phase 3 Randomized Study Comparing Teclistamab in Combination With Daratumumab SC (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma","has_exemption":false,"start_date":"2021-10-14","completion_date":"2028-12-08","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06784752","publication_url":"https://clinicaltrials.gov/study/NCT06784752","title":"A Phase III Multi-center, Randomized, Open-label Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients Newly Diagnosed With Grade 1 and Grade 2 (Ki-67 <10%) Advanced GEP-NET With High Disease Burden (NETTER-3)","has_exemption":false,"start_date":"2025-05-30","completion_date":"2028-12-08","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07559513","publication_url":"https://clinicaltrials.gov/study/NCT07559513","title":"Phase 3 Evaluation of the Safety, Pharmacokinetics, and Efficacy of Garetosmab (Anti-Activin A Monoclonal Antibody) in Children and Adolescents With Fibrodysplasia Ossificans Progressiva","has_exemption":false,"start_date":"2026-07-30","completion_date":"2028-12-10","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06093126","publication_url":"https://clinicaltrials.gov/study/NCT06093126","title":"Lemborexant for Insomnia in a Patient With Dementia: An N-of-1 Trial","has_exemption":false,"start_date":"2023-12-11","completion_date":"2028-12-11","has_results":false,"results_due":false,"sponsor_name":"Nova Scotia Health Authority","sponsor_slug":"nova-scotia-health-authority","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07282665","publication_url":"https://clinicaltrials.gov/study/NCT07282665","title":"A PHASE 3, PLACEBO-CONTROLLED, DOUBLE-BLINDED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF A CLOSTRIDIOIDES DIFFICILE VACCINE IN ADULTS 65 YEARS OF AGE AND OLDER","has_exemption":false,"start_date":"2025-12-10","completion_date":"2028-12-11","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07258511","publication_url":"https://clinicaltrials.gov/study/NCT07258511","title":"A Phase 3 Randomized Study Comparing JNJ-79635322 and an Anti-BCMAxCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy Including a PI, an IMiD, and an Anti CD38 Antibody","has_exemption":false,"start_date":"2026-02-04","completion_date":"2028-12-12","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07424144","publication_url":"https://clinicaltrials.gov/study/NCT07424144","title":"A Double-blinded Extension Study to Evaluate the Long-term Safety and Tolerability of Itepekimab in Adult Participants With Inadequately Controlled Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Who Participated in Either EFC18418 or EFC18419 Clinical Studies","has_exemption":false,"start_date":"2026-03-12","completion_date":"2028-12-12","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07400107","publication_url":"https://clinicaltrials.gov/study/NCT07400107","title":"Efficacy and Safety of NNC0487-0111 s.c. Once-weekly Compared to Semaglutide s.c. Once-weekly in Participants With Overweight or Obesity, and Type 2 Diabetes (AMAZE 8)","has_exemption":false,"start_date":"2026-05-20","completion_date":"2028-12-12","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06952660","publication_url":"https://clinicaltrials.gov/study/NCT06952660","title":"A PROSPECTIVE LOW-INTERVENTIONAL PHASE 4 SINGLE ARM STUDY OF OCULAR ASSESSMENTS IN PATIENTS TREATED WITH TIVDAK® IN RECURRENT OR METASTATIC CERVICAL CANCER","has_exemption":false,"start_date":"2025-05-07","completion_date":"2028-12-13","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07386002","publication_url":"https://clinicaltrials.gov/study/NCT07386002","title":"A Phase II, Open-Label, Multicenter Study With a Safety Run-In to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of MT027 Administrated Intracerebroventricularly in Patients With Recurrent or Progressive Glioblastoma (WHO Grade 4)","has_exemption":false,"start_date":"2026-06-30","completion_date":"2028-12-13","has_results":false,"results_due":false,"sponsor_name":"T-MAXIMUM Pharmaceutical Inc","sponsor_slug":"t-maximum-pharmaceutical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07513181","publication_url":"https://clinicaltrials.gov/study/NCT07513181","title":"A Phase 2b, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Clinical Study to Evaluate the Efficacy and Safety of ATH-063 Induction Therapy in Patients With Biologic Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)","has_exemption":false,"start_date":"2026-05-31","completion_date":"2028-12-14","has_results":false,"results_due":false,"sponsor_name":"Athos Therapeutics Inc","sponsor_slug":"athos-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06662786","publication_url":"https://clinicaltrials.gov/study/NCT06662786","title":"A Randomized, Open-label Phase 3 Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer","has_exemption":false,"start_date":"2024-10-18","completion_date":"2028-12-15","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07281716","publication_url":"https://clinicaltrials.gov/study/NCT07281716","title":"A Phase 1b/2 Study of Combination Immunotherapy for the Treatment of Chemotherapy-refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer (CRC)","has_exemption":false,"start_date":"2025-12-01","completion_date":"2028-12-15","has_results":false,"results_due":false,"sponsor_name":"Dan Feng","sponsor_slug":"dan-feng","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07293754","publication_url":"https://clinicaltrials.gov/study/NCT07293754","title":"A Phase 1/2 Trial of RPTR-1-201, a T Cell Receptor Bispecific Therapy, in Advanced Solid Tumors","has_exemption":false,"start_date":"2025-12-12","completion_date":"2028-12-15","has_results":false,"results_due":false,"sponsor_name":"Repertoire Immune Medicines","sponsor_slug":"repertoire-immune-medicines","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07282587","publication_url":"https://clinicaltrials.gov/study/NCT07282587","title":"A Phase 2 Study of ONC206 in Advanced Pheochromocytoma and Paraganglioma","has_exemption":false,"start_date":"2026-01-02","completion_date":"2028-12-15","has_results":false,"results_due":false,"sponsor_name":"Jazz Pharmaceuticals","sponsor_slug":"jazz-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07566429","publication_url":"https://clinicaltrials.gov/study/NCT07566429","title":"A Phase 2, Open-label, Single Group, Fixed-dose Study to Evaluate the Safety and Efficacy of a Single Bilateral Intraputaminal Administration of AB-1005 (AAV2-GDNF Gene Therapy) in Japanese Participants With Moderate Stage Parkinson's Disease","has_exemption":false,"start_date":"2026-07-27","completion_date":"2028-12-15","has_results":false,"results_due":false,"sponsor_name":"Bayer","sponsor_slug":"bayer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06572423","publication_url":"https://clinicaltrials.gov/study/NCT06572423","title":"Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy for Palliative Head and Neck Cancer Treatment (PULS-Pal)","has_exemption":false,"start_date":"2024-10-25","completion_date":"2028-12-16","has_results":false,"results_due":false,"sponsor_name":"Jonsson Comprehensive Cancer Center","sponsor_slug":"jonsson-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05790213","publication_url":"https://clinicaltrials.gov/study/NCT05790213","title":"Phase II Trial of Focal Prostate Ablation Combined With Androgen Deprivation Therapy for Prostate Cancer Treatment","has_exemption":false,"start_date":"2025-05-05","completion_date":"2028-12-18","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07405476","publication_url":"https://clinicaltrials.gov/study/NCT07405476","title":"A Phase II Clinical Trial of Neoadjuvant Zanidatamab for HER2+ Localized Colorectal Cancer","has_exemption":false,"start_date":"2026-04-07","completion_date":"2028-12-18","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05334368","publication_url":"https://clinicaltrials.gov/study/NCT05334368","title":"A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Depemokimab in Adults With Hypereosinophilic Syndrome (HES)","has_exemption":false,"start_date":"2022-09-06","completion_date":"2028-12-19","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07405801","publication_url":"https://clinicaltrials.gov/study/NCT07405801","title":"A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Patients With Endocrine- Resistant Hormone-Receptor-Positive, HER2-Negative Advanced Breast Cancer With Chromosome 8P Loss and Without a PIK3CA Mutation","has_exemption":false,"start_date":"2026-04-07","completion_date":"2028-12-19","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06983158","publication_url":"https://clinicaltrials.gov/study/NCT06983158","title":"A Phase 1/2a, Open-Label, Multi-Center, Dose-Escalation Trial to Assess Safety, Tolerability, and Efficacy of a Single Dose of CAP-002 Gene Therapy Administered to Pediatric Patients With Syntaxin-Binding Protein 1 (STXBP1) Encephalopathy","has_exemption":false,"start_date":"2025-07-03","completion_date":"2028-12-20","has_results":false,"results_due":false,"sponsor_name":"Capsida Biotherapeutics, Inc.","sponsor_slug":"capsida-biotherapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05723926","publication_url":"https://clinicaltrials.gov/study/NCT05723926","title":"Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation","has_exemption":false,"start_date":"2026-01-09","completion_date":"2028-12-20","has_results":false,"results_due":false,"sponsor_name":"Javelin Medical","sponsor_slug":"javelin-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06858501","publication_url":"https://clinicaltrials.gov/study/NCT06858501","title":"Concordance in Response Assessment Incorporating Meta-Iodobenzylguanidine (123I-MIBG) and Meta-[18F]Fluorobenzylguanidine (18F-MFBG, IND#146379, NSC#853868) Imaging in Neuroblastoma","has_exemption":false,"start_date":"2026-06-22","completion_date":"2028-12-20","has_results":false,"results_due":false,"sponsor_name":"Children's Oncology Group","sponsor_slug":"childrens-oncology-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04468659","publication_url":"https://clinicaltrials.gov/study/NCT04468659","title":"AHEAD 3-45 Study: A Placebo-Controlled, Double-Blind, Parallel-Treatment Arm, 216 Week Study With an Extension Phase to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subjects With Preclinical Alzheimer's Disease and Elevated Amyloid (A45 Trial) and in Subjects With Early Preclinical Alzheimer's Disease and Intermediate Amyloid (A3 Trial)","has_exemption":false,"start_date":"2020-07-14","completion_date":"2028-12-21","has_results":false,"results_due":false,"sponsor_name":"Eisai Inc.","sponsor_slug":"eisai-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06191315","publication_url":"https://clinicaltrials.gov/study/NCT06191315","title":"A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Efficacy and Longterm Safety of Dupilumab in Children 2 to <6 Years of Age With Uncontrolled Asthma and/or Recurrent Severe Asthmatic Wheeze","has_exemption":false,"start_date":"2024-01-03","completion_date":"2028-12-21","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07053423","publication_url":"https://clinicaltrials.gov/study/NCT07053423","title":"A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Dupilumab on Airway Inflammation Through Assessments of Mucus Plugging and Other Lung Imaging Parameters in Patients With Chronic Obstructive Pulmonary Disease.","has_exemption":false,"start_date":"2025-09-22","completion_date":"2028-12-23","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07549412","publication_url":"https://clinicaltrials.gov/study/NCT07549412","title":"A Randomized, Open Label, 3-arm Phase 3 Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)","has_exemption":false,"start_date":"2026-05-05","completion_date":"2028-12-25","has_results":false,"results_due":false,"sponsor_name":"EMD Serono Research & Development Institute, Inc.","sponsor_slug":"emd-serono-research-development-institute-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07205718","publication_url":"https://clinicaltrials.gov/study/NCT07205718","title":"An Open-label, Dose Escalation and Expansion, Phase 1/2 Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of TAK- 188, an Anti-CCR8 Antibody-Drug- Conjugate, as a Single Agent in Adult Participants With Locally Advanced or Metastatic Solid Tumors","has_exemption":false,"start_date":"2025-11-19","completion_date":"2028-12-26","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07421167","publication_url":"https://clinicaltrials.gov/study/NCT07421167","title":"A Phase 2 Open-label Study to Evaluate the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP) Previously Treated With at Least One Treatment (VAY2EXPLORE)","has_exemption":false,"start_date":"2026-06-29","completion_date":"2028-12-26","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01174121","publication_url":"https://clinicaltrials.gov/study/NCT01174121","title":"A Phase II Study Using Short-Term Cultured, Autologous Tumor-Infiltrating Lymphocytes Following a Lymphodepleting Regimen in Metastatic Cancers Plus the Administration of Pembrolizumab","has_exemption":false,"start_date":"2010-08-26","completion_date":"2028-12-27","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT05248659","publication_url":"https://clinicaltrials.gov/study/NCT05248659","title":"A Phase 2/3, Multicenter, Open-label Trial to Evaluate the Long-term Safety, Tolerability, and Efficacy of Sibeprenlimab Administered Subcutaneously in Subjects With Immunoglobulin A Nephropathy.","has_exemption":false,"start_date":"2022-04-05","completion_date":"2028-12-28","has_results":false,"results_due":false,"sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","sponsor_slug":"otsuka-pharmaceutical-development-commercialization-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07481981","publication_url":"https://clinicaltrials.gov/study/NCT07481981","title":"A Phase 3, Randomized, Double-Blind, Placebo-controlled, Multicenter, Parallel-group Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial Hypertension","has_exemption":false,"start_date":"2026-04-17","completion_date":"2028-12-28","has_results":false,"results_due":false,"sponsor_name":"Insmed Incorporated","sponsor_slug":"insmed-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05035836","publication_url":"https://clinicaltrials.gov/study/NCT05035836","title":"A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC)","has_exemption":false,"start_date":"2021-11-16","completion_date":"2028-12-29","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05421663","publication_url":"https://clinicaltrials.gov/study/NCT05421663","title":"A Phase 1b/2, Multicenter, Open-label, Study of JNJ-90014496, an Autologous CD19/CD20 Bi-specific CAR-T Cell Therapy in Adult Participants With B-cell Non-Hodgkin Lymphoma","has_exemption":false,"start_date":"2022-08-12","completion_date":"2028-12-29","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06396039","publication_url":"https://clinicaltrials.gov/study/NCT06396039","title":"A Phase 4, Multicenter, Single-arm, Open-label Study to Evaluate the Effectiveness and Safety of Oral Ozanimod for Relapsing Multiple Sclerosis (RMS) in Chinese Participants","has_exemption":false,"start_date":"2024-05-15","completion_date":"2028-12-29","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06962800","publication_url":"https://clinicaltrials.gov/study/NCT06962800","title":"An Open-Label, Multicenter, Randomized Phase 3 Study Evaluating the Efficacy and Safety of Felzartamab in Participants With Primary Membranous Nephropathy (PMN) [PROMINENT]","has_exemption":false,"start_date":"2025-05-22","completion_date":"2028-12-29","has_results":false,"results_due":false,"sponsor_name":"Biogen","sponsor_slug":"biogen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06855771","publication_url":"https://clinicaltrials.gov/study/NCT06855771","title":"A Multicenter, Randomized, Open-label, Phase 2 Study Evaluating the Safety and Efficacy of BMS-986504 Monotherapy in Participants With Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion After Progression on Prior Therapies","has_exemption":false,"start_date":"2025-09-09","completion_date":"2028-12-29","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07204275","publication_url":"https://clinicaltrials.gov/study/NCT07204275","title":"A Phase 2b/3 Adaptive, Randomized, Active-controlled Study Evaluating the Efficacy, Safety, and Tolerability of Povetacicept Versus Calcineurin Inhibitor in the Treatment of Primary Membranous Nephropathy","has_exemption":false,"start_date":"2025-09-30","completion_date":"2028-12-29","has_results":false,"results_due":false,"sponsor_name":"Vertex Pharmaceuticals Incorporated","sponsor_slug":"vertex-pharmaceuticals-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07284849","publication_url":"https://clinicaltrials.gov/study/NCT07284849","title":"A Randomized, Double-Blind, Phase 3 Study of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer","has_exemption":false,"start_date":"2026-03-05","completion_date":"2028-12-29","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07566195","publication_url":"https://clinicaltrials.gov/study/NCT07566195","title":"A Phase III, Multicentre, Open-Label, Chronic Dosing, Extension Study to Evaluate the Long-term Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease (COPD) With a History of COPD Exacerbations (ROMEO)","has_exemption":false,"start_date":"2026-04-30","completion_date":"2028-12-29","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03801434","publication_url":"https://clinicaltrials.gov/study/NCT03801434","title":"Phase 2 Study of Ruxolitinib in Idiopathic Hypereosinophilic Syndrome and Primary Eosinophilic Disorders","has_exemption":false,"start_date":"2019-11-15","completion_date":"2028-12-30","has_results":false,"results_due":false,"sponsor_name":"William Shomali","sponsor_slug":"william-shomali","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05183152","publication_url":"https://clinicaltrials.gov/study/NCT05183152","title":"Non-invasive Brain-computer Interfaces for Control of Assistive Devices","has_exemption":false,"start_date":"2021-06-16","completion_date":"2028-12-30","has_results":false,"results_due":false,"sponsor_name":"University of Texas at Austin","sponsor_slug":"university-of-texas-at-austin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04855630","publication_url":"https://clinicaltrials.gov/study/NCT04855630","title":"Combating Alzheimer's Through Sleep and Exercise (CASE)","has_exemption":false,"start_date":"2023-03-01","completion_date":"2028-12-30","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05897086","publication_url":"https://clinicaltrials.gov/study/NCT05897086","title":"Nerve Repair Using Hydrophilic Polymers to Improve Tactile and Erogenous Neophallus Sensation","has_exemption":false,"start_date":"2023-08-01","completion_date":"2028-12-30","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06483347","publication_url":"https://clinicaltrials.gov/study/NCT06483347","title":"Intra-tumor Delivery of Double Checkpoint Inhibitors, Chemodrug, and/or Bevacizumab Therapy as First Line for Inoperable Lung Cancer","has_exemption":false,"start_date":"2024-04-04","completion_date":"2028-12-30","has_results":false,"results_due":false,"sponsor_name":"Second Affiliated Hospital of Guangzhou Medical University","sponsor_slug":"second-affiliated-hospital-of-guangzhou-medical-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06492421","publication_url":"https://clinicaltrials.gov/study/NCT06492421","title":"Phase II Study of Neoadjuvant CT-Guided Intra-tumor Double Checkpoint Blockades for Untreated Stage I-IIIA Non-Small Cell Lung Cancers Amenable for Surgical Resection","has_exemption":false,"start_date":"2024-07-01","completion_date":"2028-12-30","has_results":false,"results_due":false,"sponsor_name":"Second Affiliated Hospital of Guangzhou Medical University","sponsor_slug":"second-affiliated-hospital-of-guangzhou-medical-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06492408","publication_url":"https://clinicaltrials.gov/study/NCT06492408","title":"Phase II Study of Neoadjuvant CT-Guided Intra-tumor Double Checkpoint Blockades for Untreated Hepatocellular Carcinoma (HCC) Amenable for Surgical Resection","has_exemption":false,"start_date":"2024-07-01","completion_date":"2028-12-30","has_results":false,"results_due":false,"sponsor_name":"Second Affiliated Hospital of Guangzhou Medical University","sponsor_slug":"second-affiliated-hospital-of-guangzhou-medical-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06644833","publication_url":"https://clinicaltrials.gov/study/NCT06644833","title":"Effectiveness of Transcranial Magnetic Stimulation (TMS) Versus Treatment as Usual for First-Episode Depression in Adult Patients. An Open-Label Randomised Controlled Trial","has_exemption":false,"start_date":"2025-01-01","completion_date":"2028-12-30","has_results":false,"results_due":false,"sponsor_name":"Sultan Qaboos University","sponsor_slug":"sultan-qaboos-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07526935","publication_url":"https://clinicaltrials.gov/study/NCT07526935","title":"Combined Role of Gastric Peroral Endoscopic Myotomy and Gastric Electrical Stimulator in the Management of Refractory Gastroparesis- A Randomized Single Blinded Control Trial","has_exemption":false,"start_date":"2025-03-19","completion_date":"2028-12-30","has_results":false,"results_due":false,"sponsor_name":"Baylor Research Institute","sponsor_slug":"baylor-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07109726","publication_url":"https://clinicaltrials.gov/study/NCT07109726","title":"A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations","has_exemption":false,"start_date":"2025-09-23","completion_date":"2028-12-30","has_results":false,"results_due":false,"sponsor_name":"Terremoto Biosciences Inc.","sponsor_slug":"terremoto-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07122713","publication_url":"https://clinicaltrials.gov/study/NCT07122713","title":"Multi-institutional Prospective Pilot Study of Definitive Breast Radiation Therapy for Invasive Breast Cancer Patients Not Undergoing Definitive Surgery","has_exemption":false,"start_date":"2025-12-08","completion_date":"2028-12-30","has_results":false,"results_due":false,"sponsor_name":"Alexander Stessin","sponsor_slug":"alexander-stessin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04993027","publication_url":"https://clinicaltrials.gov/study/NCT04993027","title":"Topical Vancomycin for Infection Prophylaxis in Total Hip and Knee Arthroplasty","has_exemption":false,"start_date":"2025-12-30","completion_date":"2028-12-30","has_results":false,"results_due":false,"sponsor_name":"Alberta Hip and Knee Clinic","sponsor_slug":"alberta-hip-and-knee-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07179380","publication_url":"https://clinicaltrials.gov/study/NCT07179380","title":"A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel Group Study to Evaluate the Efficacy and Safety of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease","has_exemption":false,"start_date":"2026-01-07","completion_date":"2028-12-30","has_results":false,"results_due":false,"sponsor_name":"Insmed Incorporated","sponsor_slug":"insmed-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07162363","publication_url":"https://clinicaltrials.gov/study/NCT07162363","title":"Synergistic Intervention of Minimally Invasive Surgery and Deferoxamine in Intracerebral Hemorrhage (SMAD)","has_exemption":false,"start_date":"2026-03-01","completion_date":"2028-12-30","has_results":false,"results_due":false,"sponsor_name":"University of Illinois at Chicago","sponsor_slug":"university-of-illinois-at-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07442461","publication_url":"https://clinicaltrials.gov/study/NCT07442461","title":"Effects of Visual Impairment on Neurophysiological Responses and the Feasibility and Impact of Multimodal Virtual Assistance for Instrumental Activities of Daily Living in Low Vision Populations","has_exemption":false,"start_date":"2026-03-01","completion_date":"2028-12-30","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07514858","publication_url":"https://clinicaltrials.gov/study/NCT07514858","title":"Interventional, Randomized, Double-blind, Parallel-group, Placebo-controlled, Flexible-dose Trial of Lu AF28996 in Adults With Parkinson's Disease Experiencing Motor Fluctuations","has_exemption":false,"start_date":"2026-06-30","completion_date":"2028-12-30","has_results":false,"results_due":false,"sponsor_name":"H. Lundbeck A/S","sponsor_slug":"h-lundbeck-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01269190","publication_url":"https://clinicaltrials.gov/study/NCT01269190","title":"Wide-Field and High Resolution In Vivo Imaging of Oral Neoplasia Using Topical Fluorescent Dyes: A Feasibility Study","has_exemption":false,"start_date":"2010-12-30","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01419561","publication_url":"https://clinicaltrials.gov/study/NCT01419561","title":"Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)","has_exemption":false,"start_date":"2011-09-08","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01570998","publication_url":"https://clinicaltrials.gov/study/NCT01570998","title":"Targeted Intraoperative Radiotherapy United States (TARGIT-US) Phase IV Registry Trial: A Registry Trial of Targeted Intraoperative Radiation Therapy Following Breast-conserving Surgery","has_exemption":false,"start_date":"2012-05-18","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02201589","publication_url":"https://clinicaltrials.gov/study/NCT02201589","title":"Proposed Single Center Investigational Device Exemption: Feasibility of Endovascular Repair Of Ascending Aortic Pathologies","has_exemption":false,"start_date":"2013-11-30","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Rodney A. White, M.D.","sponsor_slug":"rodney-a-white-md","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02000089","publication_url":"https://clinicaltrials.gov/study/NCT02000089","title":"The Cancer of the Pancreas Screening-5 CAPS5)Study","has_exemption":false,"start_date":"2014-01-06","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02266719","publication_url":"https://clinicaltrials.gov/study/NCT02266719","title":"Clinical Outcomes and Radiation Safety After Endovascular Repair of Complex Aortic Aneurysms Using Fenestrated and Branched Devices","has_exemption":false,"start_date":"2014-12-01","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02329652","publication_url":"https://clinicaltrials.gov/study/NCT02329652","title":"Multi-functional Neuroprosthetic System for Restoration of Motor Function in Spinal Cord Injury","has_exemption":false,"start_date":"2014-12-01","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Anne Bryden","sponsor_slug":"anne-bryden","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02272049","publication_url":"https://clinicaltrials.gov/study/NCT02272049","title":"Use of Hyperpolarized 129 Xe MR Lung Imaging in Children and Adults","has_exemption":false,"start_date":"2014-12-31","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02346747","publication_url":"https://clinicaltrials.gov/study/NCT02346747","title":"A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Vigil Engineered Autologous Tumor Cell Immunotherapy in Subjects With Stage IIIb-IV Ovarian Cancer in Clinical Complete Response Following Surgery and Primary Chemotherapy","has_exemption":false,"start_date":"2015-02-28","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Gradalis, Inc.","sponsor_slug":"gradalis-inc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02468024","publication_url":"https://clinicaltrials.gov/study/NCT02468024","title":"JoLT-Ca A Randomized Phase III Study of Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) in High Risk Patients With Stage I Non-Small Cell Lung Cancer (NSCLC), The STABLE-MATES Trial","has_exemption":false,"start_date":"2015-07-31","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02721732","publication_url":"https://clinicaltrials.gov/study/NCT02721732","title":"Phase II Study for the Evaluation of Efficacy of Pembrolizumab (MK-3475) in Patients With Rare Tumors","has_exemption":false,"start_date":"2016-08-15","completion_date":"2028-12-31","has_results":true,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02890485","publication_url":"https://clinicaltrials.gov/study/NCT02890485","title":"The Effects of Dry Needling on Patients With Knee Pain","has_exemption":false,"start_date":"2016-08-31","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02784210","publication_url":"https://clinicaltrials.gov/study/NCT02784210","title":"The Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques: An Investigator-Blinded Study","has_exemption":false,"start_date":"2016-10-05","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"National Institute of Neurological Disorders and Stroke (NINDS)","sponsor_slug":"national-institute-of-neurological-disorders-and-stroke-ninds","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03013998","publication_url":"https://clinicaltrials.gov/study/NCT03013998","title":"A Master Protocol for Biomarker-Based Treatment of AML (The Beat AML Trial)","has_exemption":false,"start_date":"2016-11-30","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Beat AML, LLC","sponsor_slug":"beat-aml-llc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03096197","publication_url":"https://clinicaltrials.gov/study/NCT03096197","title":"Exoskeleton and Spinal Cord Stimulation for SCI","has_exemption":false,"start_date":"2017-03-30","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Kessler Foundation","sponsor_slug":"kessler-foundation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03215719","publication_url":"https://clinicaltrials.gov/study/NCT03215719","title":"Adaptive De-escalation of Radiation Therapy Dose in HPV-Positive Oropharyngeal Carcinoma (ART) Demonstrating Favorable Mid-Treatment Response","has_exemption":false,"start_date":"2017-10-18","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05363436","publication_url":"https://clinicaltrials.gov/study/NCT05363436","title":"Successful Implementation of an Opioid Reduction Toolkit in Pancreatectomy Patients Significantly Decreases Number of Opioids Prescribed and Consumed","has_exemption":false,"start_date":"2018-01-01","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Thomas Jefferson University","sponsor_slug":"thomas-jefferson-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03906253","publication_url":"https://clinicaltrials.gov/study/NCT03906253","title":"Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia","has_exemption":false,"start_date":"2018-01-10","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Wright State University","sponsor_slug":"wright-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03385993","publication_url":"https://clinicaltrials.gov/study/NCT03385993","title":"Digital Rehabilitation Environment Augmenting Medical System","has_exemption":false,"start_date":"2018-01-16","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03530592","publication_url":"https://clinicaltrials.gov/study/NCT03530592","title":"Seated Ankle Robot for Foot Drop in Aging and Disabled Populations: A Demonstration Project","has_exemption":false,"start_date":"2018-06-01","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Baltimore VA Medical Center","sponsor_slug":"baltimore-va-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03556709","publication_url":"https://clinicaltrials.gov/study/NCT03556709","title":"Walking Ankle Robot for Foot Drop in Aging and Disabled Populations: A Demonstration Project","has_exemption":false,"start_date":"2018-08-01","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Baltimore VA Medical Center","sponsor_slug":"baltimore-va-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03711175","publication_url":"https://clinicaltrials.gov/study/NCT03711175","title":"A Prospective Multicenter Study to Examine the Influence of Repairing the Sub-scapularis on Outcomes After Reverse Arthroplasty: A Randomized, Controlled Trial.","has_exemption":false,"start_date":"2018-09-28","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Encore Medical, L.P.","sponsor_slug":"encore-medical-lp","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03449238","publication_url":"https://clinicaltrials.gov/study/NCT03449238","title":"Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients","has_exemption":false,"start_date":"2018-11-15","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03714503","publication_url":"https://clinicaltrials.gov/study/NCT03714503","title":"Head Positioning Duration After Retinal Detachment Repair With Vitrectomy and Gas","has_exemption":false,"start_date":"2019-04-08","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Kansas Medical Center","sponsor_slug":"university-of-kansas-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03991169","publication_url":"https://clinicaltrials.gov/study/NCT03991169","title":"Pilot Pragmatic Clinical Trial of Oral Iron Therapy in Children With Chronic Kidney Disease","has_exemption":false,"start_date":"2019-04-19","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03686124","publication_url":"https://clinicaltrials.gov/study/NCT03686124","title":"Phase 1/2 Study Evaluating Genetically Modified Autologous T Cells Expressing a TCR Recognizing a Cancer/Germline Antigen as Monotherapy or in Combination With Nivolumab in Patients With Recurrent and/or Refractory Solid Tumors","has_exemption":false,"start_date":"2019-05-14","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Immatics US, Inc.","sponsor_slug":"immatics-us-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03866668","publication_url":"https://clinicaltrials.gov/study/NCT03866668","title":"An Open-Label Pilot Study of Esomeprazole in Children With Autism","has_exemption":false,"start_date":"2019-05-29","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03999801","publication_url":"https://clinicaltrials.gov/study/NCT03999801","title":"A Long-term Follow-Up Study to Evaluate the Safety and Efficacy of RGX-314 Following Subretinal Administration in Participants With Neovascular Age-related Macular Degeneration and Fellow Eye Treatment Substudy","has_exemption":false,"start_date":"2019-05-31","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03968393","publication_url":"https://clinicaltrials.gov/study/NCT03968393","title":"Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress - The ASPIRE-AF Trial","has_exemption":false,"start_date":"2019-06-14","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Population Health Research Institute","sponsor_slug":"population-health-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06902623","publication_url":"https://clinicaltrials.gov/study/NCT06902623","title":"A Phase II Study of Treatment De-Escalation for Favorable Prognosis, Stage I-II Human Papilloma Virus (HPV) or p16-Positive Oropharyngeal Cancer Receiving Definitive Radiotherapy","has_exemption":false,"start_date":"2019-08-01","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Georgetown University","sponsor_slug":"georgetown-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03980717","publication_url":"https://clinicaltrials.gov/study/NCT03980717","title":"A Prospective Study on the Role of Fetal Endotracheal Occlusion (FETO) in the Resolution of Pulmonary Hypertension Among Fetuses With Severe Congenital Diaphragmatic Hernia","has_exemption":false,"start_date":"2019-08-09","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Michael A Belfort","sponsor_slug":"michael-a-belfort","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04047784","publication_url":"https://clinicaltrials.gov/study/NCT04047784","title":"Pilot Study to Evaluate the Role of Endobronchial Ultrasound (EBUS) in the Diagnosis of Acute Pulmonary Embolism in Critically Ill Patients","has_exemption":false,"start_date":"2019-08-12","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04204252","publication_url":"https://clinicaltrials.gov/study/NCT04204252","title":"Prospective Phase 3 Multi-center 2-Year Placebo Controlled Double Blind Study to Evaluate the Efficacy and Safety of Kamada-AAT for Inhalation 80 mg/Day in Alpha-1 Antitrypsin Deficiency With Moderate and Severe Airflow Limitation Followed by a 2-Year Open Label Extension","has_exemption":false,"start_date":"2019-11-25","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Kamada, Ltd.","sponsor_slug":"kamada-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03240809","publication_url":"https://clinicaltrials.gov/study/NCT03240809","title":"An Open-label, Single-dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Brodalumab in Pediatric Subjects (6 to < 18 Years Old) With Severe Plaque Psoriasis","has_exemption":false,"start_date":"2020-01-24","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Bausch Health Americas, Inc.","sponsor_slug":"bausch-health-americas-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04249830","publication_url":"https://clinicaltrials.gov/study/NCT04249830","title":"Allogeneic Hematopoietic Stem Cell Transplantation From an HLA-partially Matched Related or Unrelated Donor After TCR αβ+T Cells/CD19+ B Cell Depletion in Children and Young Adults Affected by Malignant or Non-Malignant Hematological Disorders","has_exemption":false,"start_date":"2020-02-01","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Alice Bertaina","sponsor_slug":"alice-bertaina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03324425","publication_url":"https://clinicaltrials.gov/study/NCT03324425","title":"A Phase II Single Arm Trial of Adding Simvastatin to Dual Anti-HER2 Therapy in Patients With HER2-Positive Metastatic Breast Cancer","has_exemption":false,"start_date":"2020-03-04","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Baylor Breast Care Center","sponsor_slug":"baylor-breast-care-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04092283","publication_url":"https://clinicaltrials.gov/study/NCT04092283","title":"Randomized Phase III Trial of MEDI4736 (Durvalumab) as Concurrent and Consolidative Therapy or Consolidative Therapy Alone for Unresectable Stage 3 NSCLC","has_exemption":false,"start_date":"2020-04-29","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06491758","publication_url":"https://clinicaltrials.gov/study/NCT06491758","title":"Effect of Electrical Stimulation of the Auricular Branch of the Vagus Nerve (ABVN) on Cervical Vagus Nerve Action Potentials Phase 2","has_exemption":false,"start_date":"2020-06-02","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03936361","publication_url":"https://clinicaltrials.gov/study/NCT03936361","title":"STATINS USE IN INTRACEREBRAL HEMORRHAGE PATIENTS","has_exemption":false,"start_date":"2020-06-10","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04474223","publication_url":"https://clinicaltrials.gov/study/NCT04474223","title":"Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)","has_exemption":false,"start_date":"2020-08-01","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04604509","publication_url":"https://clinicaltrials.gov/study/NCT04604509","title":"PISCES I: Precision Implemented Smoking Cessation Evaluation Study","has_exemption":false,"start_date":"2020-08-04","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04575935","publication_url":"https://clinicaltrials.gov/study/NCT04575935","title":"Laparoscopic Cytoreduction After Neoadjuvant Chemotherapy","has_exemption":false,"start_date":"2020-08-05","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04340141","publication_url":"https://clinicaltrials.gov/study/NCT04340141","title":"A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer","has_exemption":false,"start_date":"2020-10-13","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Alliance for Clinical Trials in Oncology","sponsor_slug":"alliance-for-clinical-trials-in-oncology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04222062","publication_url":"https://clinicaltrials.gov/study/NCT04222062","title":"A Randomized Trial Evaluating GLIADEL Compared to Stereotactic Radiosurgery in Subjects With Metastatic Brain Disease","has_exemption":false,"start_date":"2020-11-06","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Nebraska","sponsor_slug":"university-of-nebraska","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04616183","publication_url":"https://clinicaltrials.gov/study/NCT04616183","title":"Open-Label Phase 1b/2 Study of Cetuximab Administered in Combination With LY3214996 (ERK 1/2 Inhibitor) or Cetuximab in Combination With LY3214996 and Abemaciclib in Patients With Metastatic, Anti-EGFR-Refractory Colorectal Cancer","has_exemption":false,"start_date":"2020-12-02","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04659317","publication_url":"https://clinicaltrials.gov/study/NCT04659317","title":"A Double-Blinded Randomized Controlled Trial Examining Multimodal Opioid-Free Orthopaedic Procedures","has_exemption":false,"start_date":"2020-12-11","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04419480","publication_url":"https://clinicaltrials.gov/study/NCT04419480","title":"Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial","has_exemption":false,"start_date":"2020-12-31","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Inova Health Care Services","sponsor_slug":"inova-health-care-services","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04901936","publication_url":"https://clinicaltrials.gov/study/NCT04901936","title":"An Open Label, Single-Arm, Phase 2 Study to Evaluate the Safety, Pharmacokinetics, and Biologic Activity of Pegcetacoplan in Pediatric Patients With Paroxysmal Nocturnal Hemoglobinuria","has_exemption":false,"start_date":"2021-02-04","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Apellis Pharmaceuticals, Inc.","sponsor_slug":"apellis-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04648046","publication_url":"https://clinicaltrials.gov/study/NCT04648046","title":"Safety and Anti-HIV Activity of Autologous CD4+ and CD8+ T Cells Transduced With a Lentiviral Vector Encoding Bi-specific Anti-gp120 CAR Molecules (LVgp120duoCAR-T) in Anti-retroviral Drug-treated HIV-1 Infection","has_exemption":false,"start_date":"2021-03-01","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Steven Deeks","sponsor_slug":"steven-deeks","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04373564","publication_url":"https://clinicaltrials.gov/study/NCT04373564","title":"Prospective Evaluation of Potential Effects of Repeated Gadolinium-based Contrast Agent (GBCA) Administrations of the Same GBCA on Motor and Cognitive Functions in Neurologically Normal Adults in Comparison to a Non-GBCA Exposed Control Group","has_exemption":false,"start_date":"2021-03-24","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Guerbet","sponsor_slug":"guerbet","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04234386","publication_url":"https://clinicaltrials.gov/study/NCT04234386","title":"GCC 1926- Phase Ib Dose Escalation of Single-Fraction Preoperative Stereotactic Partial-Breast Irradiation for Early-Stage Breast Cancer","has_exemption":false,"start_date":"2021-09-15","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04800913","publication_url":"https://clinicaltrials.gov/study/NCT04800913","title":"The Role of Multimodality Imaging in Left Atrial Appendage Closure","has_exemption":false,"start_date":"2021-11-08","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Hungarian Institute of Cardiology","sponsor_slug":"hungarian-institute-of-cardiology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04750928","publication_url":"https://clinicaltrials.gov/study/NCT04750928","title":"A Phase 0/I/II Study of the Cyclin-Dependent Kinase(CDK)4/6 Inhibitor Abemaciclib for Neurofibromatosis Type 1 (NF1) Related Atypical Neurofibromas","has_exemption":false,"start_date":"2021-11-29","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04645160","publication_url":"https://clinicaltrials.gov/study/NCT04645160","title":"Phase II Study Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers","has_exemption":false,"start_date":"2022-03-04","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05017935","publication_url":"https://clinicaltrials.gov/study/NCT05017935","title":"RADIANCE Continued Access Protocol (RADIANCE CAP): A Study of the ReCor Medical Paradise System in Clinical Hypertension","has_exemption":false,"start_date":"2022-05-04","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"ReCor Medical, Inc.","sponsor_slug":"recor-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05206500","publication_url":"https://clinicaltrials.gov/study/NCT05206500","title":"Clinical Implication of Next Generation Sequencing of Urinary Bacteria in Patients With Low Colony Forming Units of Bacteria in Traditional Urine Culture","has_exemption":false,"start_date":"2022-05-17","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05312892","publication_url":"https://clinicaltrials.gov/study/NCT05312892","title":"Sympathetic Mechanisms in the Cardiovascular and Metabolic Alterations of Obesity, Crossover Design Study.","has_exemption":false,"start_date":"2022-05-20","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05441488","publication_url":"https://clinicaltrials.gov/study/NCT05441488","title":"A 96-Week, Prospective, Multicenter, Randomised, Double-Blind, Placebo-Controlled, Phase 3 Study to Compare Efficacy and Safety of Masitinib Dose Titration to 4.5 mg/kg/Day Versus Placebo in the Treatment of Patients With Primary Progressive or Secondary Progressive Multiple Sclerosis Without Relapse","has_exemption":false,"start_date":"2022-06-28","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"AB Science","sponsor_slug":"ab-science","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04991116","publication_url":"https://clinicaltrials.gov/study/NCT04991116","title":"An Open-Label Extension Study to Evaluate Long Term Safety and Efficacy of Tildrakizumab in Patients With Psoriatic Arthritis.","has_exemption":false,"start_date":"2022-06-30","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Sun Pharmaceutical Industries Limited","sponsor_slug":"sun-pharmaceutical-industries-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04648280","publication_url":"https://clinicaltrials.gov/study/NCT04648280","title":"A Multicenter, Open-label, Single-arm Trial to Evaluate the Safety, Pharmacokinetics and Antiviral Activity of Fostemsavir in Combination With Optimized Background Therapy (OBT) in HIV-1 Infected Children and Adolescents Who Are Failing Their Current Combination Antiretroviral Therapy (cART) and Have Dual- or Triple-class Antiretroviral (ARV) Resistance","has_exemption":false,"start_date":"2022-06-30","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"PENTA Foundation","sponsor_slug":"penta-foundation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05288777","publication_url":"https://clinicaltrials.gov/study/NCT05288777","title":"A Study of Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast Cancer","has_exemption":false,"start_date":"2022-07-11","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Virginia","sponsor_slug":"university-of-virginia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05388773","publication_url":"https://clinicaltrials.gov/study/NCT05388773","title":"Phase II Trial of Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer","has_exemption":false,"start_date":"2022-07-20","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Heath Skinner","sponsor_slug":"heath-skinner","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05367037","publication_url":"https://clinicaltrials.gov/study/NCT05367037","title":"Physiological Ventricular Pacing Versus Managed Ventricular Pacing for Persistent Atrial Fibrillation Prevention in Patients With Prolonged Atrioventricular Interval: a Multicenter RCT","has_exemption":false,"start_date":"2022-07-27","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Quovadis Associazione","sponsor_slug":"quovadis-associazione","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05305911","publication_url":"https://clinicaltrials.gov/study/NCT05305911","title":"Sodium Glucose Co-Transporter 2 (SGLT2) Inhibition Improves Left Ventricular Function and Reduces Adverse Left-Ventricular Remodeling in High-Risk Patients with Microvascular Obstruction (MVO) Following ST-elevation Myocardial Infarction (STEMI).","has_exemption":false,"start_date":"2022-08-03","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Minneapolis Heart Institute Foundation","sponsor_slug":"minneapolis-heart-institute-foundation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05155046","publication_url":"https://clinicaltrials.gov/study/NCT05155046","title":"Phase II Trial of 18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy","has_exemption":false,"start_date":"2022-08-31","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05524584","publication_url":"https://clinicaltrials.gov/study/NCT05524584","title":"Phase II, Open-Labeled, Single-Armed Combination Treatment With Anastrozole, Fulvestrant and Abemaciclib for Hormone Receptor Positive, HER2(-) Metastatic Breast Cancer","has_exemption":false,"start_date":"2022-08-31","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Irvine","sponsor_slug":"university-of-california-irvine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05269459","publication_url":"https://clinicaltrials.gov/study/NCT05269459","title":"Safety and Efficacy of Cannabidiol (CBD) for Symptoms of Post-Traumatic Stress Disorder (PTSD) in Adults Using Liquid StructureTM Formulation (NantheiaTM ATL5).","has_exemption":false,"start_date":"2022-12-01","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Nebraska","sponsor_slug":"university-of-nebraska","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05102721","publication_url":"https://clinicaltrials.gov/study/NCT05102721","title":"A Phase 1b/2 Trial of Immunotherapy With Avelumab and Pepinemab As Second Line For Patients With Metastatic Pancreatic Adenocarcinoma","has_exemption":false,"start_date":"2022-12-10","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Vaccinex Inc.","sponsor_slug":"vaccinex-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05640999","publication_url":"https://clinicaltrials.gov/study/NCT05640999","title":"A Phase II Study of Tailored Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endormetrial Cancer (RAINBO BLUE & TAPER)","has_exemption":false,"start_date":"2022-12-19","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Canadian Cancer Trials Group","sponsor_slug":"canadian-cancer-trials-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05641831","publication_url":"https://clinicaltrials.gov/study/NCT05641831","title":"A Randomized Double-Blind Placebo-Controlled Phase II Multi-Center Study of Inflammation Modification of Canakinumab to Prevent Leukemic Progression of Clonal Cytopenias of Unknown Significance (CCUS): IMPACT Study","has_exemption":false,"start_date":"2023-02-06","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Uma Borate","sponsor_slug":"uma-borate","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05394337","publication_url":"https://clinicaltrials.gov/study/NCT05394337","title":"Neoadjuvant PD-1 Plus TIGIT Blockade in Patients With Cisplatin-Ineligible Operable High-Risk Urothelial Carcinoma","has_exemption":false,"start_date":"2023-02-23","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05339061","publication_url":"https://clinicaltrials.gov/study/NCT05339061","title":"A Single-Arm, Single-Center, Non-Randomized, Prospective Clinical Study to Evaluate the Safety and Effectiveness of Physician Modified Endograft for Complex Abdominal and Thoracoabdominal Aortic Aneurysm Repair","has_exemption":false,"start_date":"2023-03-01","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05773755","publication_url":"https://clinicaltrials.gov/study/NCT05773755","title":"Deep Brain Stimulation for Treatment Resistant Depression: Exploration of Local Field Potentials (LFPs) With the Medtronic Percept PC System","has_exemption":false,"start_date":"2023-03-01","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Helen Mayberg, MD","sponsor_slug":"helen-mayberg-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04339374","publication_url":"https://clinicaltrials.gov/study/NCT04339374","title":"Diagnosis and Risk Assessment of Locally Advanced Rectal Cancer Using Co-registered Ultrasound and Photoacoustic Imaging","has_exemption":false,"start_date":"2023-05-01","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05826535","publication_url":"https://clinicaltrials.gov/study/NCT05826535","title":"A Phase 1/2 Multi-Center Study Evaluating the Safety and Efficacy of Rondecabtagene Autoleucel, a CD19/CD20 Dual-Targeting Chimeric Antigen Receptor T-Cell Therapy in Participants With Aggressive B-Cell Non-Hodgkin Lymphoma","has_exemption":false,"start_date":"2023-05-09","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Lyell Immunopharma, Inc.","sponsor_slug":"lyell-immunopharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05230459","publication_url":"https://clinicaltrials.gov/study/NCT05230459","title":"A Two-part Multicenter Study: a Randomized, Double-blind, Placebo-controlled Dose-escalation Safety Phase (Part 1) Followed by Double-blind, Placebo-controlled, Adaptive Phase (Part 2) Study to Evaluate the Safety and Efficacy of AB-1003 in Adult Subjects With LGMD2I/R9 Mutations in the Gene Encoding Fukutin Related Protein (FKRP)","has_exemption":false,"start_date":"2023-05-15","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"AskBio Inc","sponsor_slug":"askbio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05869812","publication_url":"https://clinicaltrials.gov/study/NCT05869812","title":"Influence of β-hydroxy β-methyl Butyrate (HMB)Supplementation on Post-operative Muscle Mass and Function in Female Athletes","has_exemption":false,"start_date":"2023-05-29","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Kansas Medical Center","sponsor_slug":"university-of-kansas-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05557370","publication_url":"https://clinicaltrials.gov/study/NCT05557370","title":"Prospective Analysis of Immunogenicity of the Nonavalent Human Papillomavirus Vaccination (GARDASIL 9) in Patients Post Solid Organ Transplant","has_exemption":false,"start_date":"2023-06-01","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05664126","publication_url":"https://clinicaltrials.gov/study/NCT05664126","title":"Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus Infections After Hematopoietic Cell Transplantation","has_exemption":false,"start_date":"2023-08-01","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"St. Jude Children's Research Hospital","sponsor_slug":"st-jude-childrens-research-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05583708","publication_url":"https://clinicaltrials.gov/study/NCT05583708","title":"A Single Arm Study With Safety Run-in of Peptide Receptor Radionuclide Therapy (PRRT) in Combination With Immunotherapy for Patients With Merkel Cell Cancer (HCRN MCC20-443; iPRRT Study)","has_exemption":false,"start_date":"2023-08-03","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06025630","publication_url":"https://clinicaltrials.gov/study/NCT06025630","title":"Targeting Endoplasmic Reticulum Stress in Human Hypertension","has_exemption":false,"start_date":"2023-08-15","completion_date":"2028-12-31","has_results":false,"results_due":false,"sponsor_name":"University of North Texas Health Science Center","sponsor_slug":"university-of-north-texas-health-science-center","status":"ongoing","is_pact":false,"days_late":null}]}